<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Front Immunol</journal-id>
<journal-id journal-id-type="iso-abbrev">Front Immunol</journal-id>
<journal-id journal-id-type="publisher-id">Front. Immunol.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Immunology</journal-title>
</journal-title-group>
<issn pub-type="epub">1664-3224</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28588585</article-id>
<article-id pub-id-type="pmc">5440529</article-id>
<article-id pub-id-type="doi">10.3389/fimmu.2017.00598</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Immunology</subject>
<subj-group>
<subject>Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Leaky Gut As a Danger Signal for Autoimmune Diseases</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Mu</surname>
<given-names>Qinghui</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="http://frontiersin.org/people/u/274348" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kirby</surname>
<given-names>Jay</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Reilly</surname>
<given-names>Christopher M.</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="http://frontiersin.org/people/u/222422" xlink:type="simple"></uri>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Luo</surname>
<given-names>Xin M.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="corresp" rid="cor1">*</xref>
<uri xlink:href="http://frontiersin.org/people/u/216884" xlink:type="simple"></uri>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Department of Biomedical Sciences and Pathobiology, Virginia-Maryland College of Veterinary Medicine, Virginia Tech</institution>, <addr-line>Blacksburg, VA</addr-line>, <country>USA</country></aff>
<aff id="aff2"><sup>2</sup><institution>Edward Via College of Osteopathic Medicine</institution>, <addr-line>Blacksburg, VA</addr-line>, <country>USA</country></aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Larry J. Dishaw, University of South Florida St. Petersburg, USA</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Rajendra Karki, St. Jude Children’s Research Hospital, USA; Lisa Rizzetto, Fondazione Edmund Mach, Italy</p>
</fn>
<corresp content-type="corresp" id="cor1">*Correspondence: Xin M. Luo, <email>xinluo@vt.edu</email></corresp>
<fn fn-type="other" id="fn001">
<p>Specialty section: This article was submitted to Molecular Innate Immunity, a section of the journal Frontiers in Immunology</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>23</day>
<month>5</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="collection">
<year>2017</year>
</pub-date>
<volume>8</volume>
<elocation-id>598</elocation-id>
<history>
<date date-type="received">
<day>27</day>
<month>3</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>05</day>
<month>5</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2017 Mu, Kirby, Reilly and Luo.</copyright-statement>
<copyright-year>2017</copyright-year>
<copyright-holder>Mu, Kirby, Reilly and Luo</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<p>The intestinal epithelial lining, together with factors secreted from it, forms a barrier that separates the host from the environment. In pathologic conditions, the permeability of the epithelial lining may be compromised allowing the passage of toxins, antigens, and bacteria in the lumen to enter the blood stream creating a “leaky gut.” In individuals with a genetic predisposition, a leaky gut may allow environmental factors to enter the body and trigger the initiation and development of autoimmune disease. Growing evidence shows that the gut microbiota is important in supporting the epithelial barrier and therefore plays a key role in the regulation of environmental factors that enter the body. Several recent reports have shown that probiotics can reverse the leaky gut by enhancing the production of tight junction proteins; however, additional and longer term studies are still required. Conversely, pathogenic bacteria that can facilitate a leaky gut and induce autoimmune symptoms can be ameliorated with the use of antibiotic treatment. Therefore, it is hypothesized that modulating the gut microbiota can serve as a potential method for regulating intestinal permeability and may help to alter the course of autoimmune diseases in susceptible individuals.</p>
</abstract>
<kwd-group>
<kwd>leaky gut</kwd>
<kwd>microbial translocation</kwd>
<kwd>gut microbiota</kwd>
<kwd>probiotics</kwd>
<kwd>autoimmunity</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source id="cn01">National Institute of Allergy and Infectious Diseases<named-content content-type="fundref-id">10.13039/100000060</named-content></funding-source>
<award-id rid="cn01">R03AI117597</award-id>
</award-group>
</funding-group>
<counts>
<fig-count count="1"></fig-count>
<table-count count="0"></table-count>
<equation-count count="0"></equation-count>
<ref-count count="143"></ref-count>
<page-count count="10"></page-count>
<word-count count="9448"></word-count>
</counts>
</article-meta>
</front>
<body>
<sec id="S1" sec-type="introduction">
<title>Introduction</title>
<p>For digestion and absorption purposes, mammals have developed a very complicated and highly specialized gastrointestinal system maintained by the mucosal barrier (<xref ref-type="bibr" rid="B1">1</xref>). However, apart from absorbable nutrients, the intestinal mucosa also faces tremendous exterior antigens, including food antigens, commensal bacteria, pathogens, and toxins. Thus, a specialized barrier function is required to block the entry of diverse exterior antigens while absorbing nutrients. Impressively, in the intestine, the front line of this barrier is maintained by only a single layer of specialized epithelial cells that are linked together by tight junction (TJ) proteins. Many other factors aid in support of this barrier including mucins, antimicrobial molecules, immunoglobulins, and cytokines. If any abnormalities occur among these factors, the intestinal permeability may increase, which is termed a “leaky gut.” A leaky gut allows the entry of exterior antigens from the gut lumen into the host, which may promote both local and systemic immune responses. Multiple diseases may arise or be exacerbated due to a leaky gut, including autoimmune diseases such as inflammatory bowel disease, celiac disease, autoimmune hepatitis, type 1 diabetes (T1D), multiple sclerosis, and systemic lupus erythematosus (SLE) (<xref ref-type="bibr" rid="B2">2</xref>–<xref ref-type="bibr" rid="B6">6</xref>). Numerous factors can affect gut permeability, such as various diet-derived compounds, alcohol consumption, and gut microbiota dysbiosis. While this review is focused on chronic inflammation and gut barrier functions in mammals, it is worth noting that leaky gut is a phenomenon that is widespread in both mammalian and non-mammalian animals (<xref ref-type="bibr" rid="B7">7</xref>). Thus, studies in systems outside of mammals, such as zebrafish (<xref ref-type="bibr" rid="B7">7</xref>, <xref ref-type="bibr" rid="B8">8</xref>), can be also helpful in our understanding of the relationship between inflammation and the intestinal barrier.</p>
<p>The gut microbiota has drawn intense attention in the past decade (<xref ref-type="bibr" rid="B9">9</xref>). Although scientists have studied gut microbiota for many years, recent advancements in molecular biology including next-generation sequencing technology has enabled researchers to gain new insight in this research field. While we are still far away from clearly understanding the exact roles and effecting modes of gut microbiota, growing evidence suggests that gut microbiota is important in modulating gut permeability and intestinal barrier functions. In this review, we summarize recent advances in the understanding of the leaky gut, bacterial translocation, and gut microbiota dysbiosis, with a particular focus on their association with extraintestinal autoimmune diseases, such as T1D and SLE.</p>
</sec>
<sec id="S2">
<title>The Intestinal Barrier</title>
<p>A large variety of exogenous substances colonize the gut lumen, such as microorganisms, toxins, and antigens. Without an intact and properly functioning intestinal barrier, these substances can penetrate the tissues beneath the intestinal epithelial lining, diffuse into blood and lymphatic circulations, and disrupt tissue homeostasis. However, there is an efficient multifaceted intestinal barrier system with physical, biochemical, and immunological components that prevents the entry of most pathogens (Figure <xref ref-type="fig" rid="F1">1</xref>). These components coordinate with each other to prevent uncontrolled translocation of luminal contents into the body. Below is a brief synopsis of the main components comprising the intestinal barrier.</p>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption>
<p><bold>Illustration of host intestinal barriers, including physical barrier (epithelium, tight junctions, mucus, commensal bacteria), biomedical barrier [antimicrobial proteins (AMPs)], and immunological barrier (lymphocytes and IgA)</bold>. Also shown is the microbial translocation to remote tissues (for example, kidney and pancreas) in the presence of a leaky gut.</p>
</caption>
<graphic xlink:href="fimmu-08-00598-g001"></graphic>
</fig>
<sec id="S2-1">
<title>Physical Barrier</title>
<p>In humans, the intestinal epithelium covers as large as 400 m<sup>2</sup> of surface area (<xref ref-type="bibr" rid="B1">1</xref>). Though only a single layer of cells, the intestinal epithelial cells (IECs) are the mainstay of the intestinal barrier and serve as a physical barrier (Figure <xref ref-type="fig" rid="F1">1</xref>). There are at least seven types of functional IECs—enterocytes, goblet cells, Paneth cells, microfold cells (M cells), enteroendocrine cells, cup cells, and tuft cells, although the functions of the last two cell populations are not well understood (<xref ref-type="bibr" rid="B10">10</xref>). Among all these cell types, enterocytes represent the absolute majority, accounting for at least 90% of crypt cells or villus cells. Enterocytes are absorptive cells and vital for nutrient uptake. However, growing evidence indicates that the functions of enterocytes are not limited to nutrient absorption. For example, enterocytes can control the abundance of Gram-positive bacteria by expressing RegIIIγ, one type of antimicrobial proteins (AMPs) (<xref ref-type="bibr" rid="B11">11</xref>–<xref ref-type="bibr" rid="B13">13</xref>). All epithelial cell types originate from Lgr5<sup>+</sup> intestinal epithelial stem cells, which reside within the crypts (<xref ref-type="bibr" rid="B14">14</xref>). The turnover rate of IECs is high and the cells are renewed every 3–5 days in the mammalian intestine (<xref ref-type="bibr" rid="B10">10</xref>, <xref ref-type="bibr" rid="B15">15</xref>), with the exception being the Paneth cells, which have a life span of about 2 months.</p>
<p>The IEC lining is continuous, and the contact between IECs is sealed by TJs (<xref ref-type="bibr" rid="B16">16</xref>). The paracellular pathway, in contrast to transcellular pathway, allows the transport of substances across the gut epithelium through the spaces between IECs. A large variety of molecules, mainly proteins, control the plasticity of TJs. More than 40 TJ proteins have been recognized, including occludin, claudins, junctional adhesion molecule A, and tricellulin (<xref ref-type="bibr" rid="B17">17</xref>). Under various pathological conditions, paracellular permeability may be increased, resulting in the entry of unwelcome, potentially harmful molecules.</p>
<p>On top of the gut epithelium, there are two layers of mucus, the inner and outer layers, that cover the whole intestinal epithelial lining and provide physical protection to separate luminal microorganisms from the epithelium. Organized by its major component, a highly glycosylated gel-forming mucin MUC2, the mucus contains diverse molecules including IgA as well as enzymes and proteins, such as lactoferrin (<xref ref-type="bibr" rid="B18">18</xref>). Goblet cells are the central cell type for the formation of mucus. They not only produce MUC2 mucin but also secret other mucus components such as ZG16, AGR2, FCGBP, CLCA1, and TFF3 (<xref ref-type="bibr" rid="B19">19</xref>, <xref ref-type="bibr" rid="B20">20</xref>). Colitis would spontaneously develop in Muc2-deficient mice, indicating a critical role for MUC2 in mucosal protection (<xref ref-type="bibr" rid="B21">21</xref>). In addition to gel-forming mucins, there is another type of mucin that is in close proximity to epithelial cells, called transmembrane mucins. Enterocytes are the main producers of transmembrane mucins (<xref ref-type="bibr" rid="B20">20</xref>).</p>
<p>The gut commensal bacteria have been described as one component of the intestinal physical barrier primarily due to its two major functions (<xref ref-type="bibr" rid="B22">22</xref>). The first is to promote resistance to the colonization of harmful or pathogenic bacteria species by competing for nutrients, occupying attachment sites, and releasing antimicrobial substances (<xref ref-type="bibr" rid="B23">23</xref>, <xref ref-type="bibr" rid="B24">24</xref>). Additionally, the gut microbiota regulates the digestion and absorption of nutrients to supply energy to epithelial cells, which are a major component of the physical barrier (<xref ref-type="bibr" rid="B25">25</xref>). A good example of the direct energy supply is the production of short-chain fatty acids by the gut microbiota, which are used by colonocytes for their development and metabolism (<xref ref-type="bibr" rid="B26">26</xref>). Taken together, IECs, the mucus layers, and gut microbial residents serve as the physical barrier to limit the entry of unfriendly luminal contents into host tissues.</p>
</sec>
<sec id="S2-2">
<title>Biochemical Barrier</title>
<p>Biochemical molecules with antimicrobial properties exist in the mucus as well as far into the lumen and include bile acids and AMPs (<xref ref-type="bibr" rid="B27">27</xref>, <xref ref-type="bibr" rid="B28">28</xref>) (Figure <xref ref-type="fig" rid="F1">1</xref>). These diverse molecules form a complicated network to reduce the load of colonized bacteria and decrease the chance of contact between luminal antigens and host cells. They are a good supplement to the physical barrier and an essential component of the intestinal barrier function.</p>
<p>The proximal small intestine harbors very few microorganisms (<xref ref-type="bibr" rid="B29">29</xref>). But as the distance from the stomach increases, the pH rises and the number of colonized bacteria esculates (<xref ref-type="bibr" rid="B30">30</xref>). Facing a large number of microorganisms, which likely outnumber the number of host cells, multiple AMPs are generated to fight against invaders. These AMPs are divided into several types, including α- and β-defensins, C-type lectin, cathelicidin, lysozyme, and intestinal alkaline phosphatase (IAP) (<xref ref-type="bibr" rid="B27">27</xref>). Their detailed antimicrobial mechanisms are discussed elsewhere (<xref ref-type="bibr" rid="B31">31</xref>). As a major, but not exclusive, producer of AMPs, Paneth cells support and mediate the biochemical barrier function.</p>
</sec>
<sec id="S2-3">
<title>Immunological Barrier</title>
<p>Below the intestinal epithelium, there are organized lymphoid follicles, including the Peyer’s patches and isolated lymphoid follicles. Inside the follicles, a variety of immune cells, including B cells, T cells, dendritic cells (DCs), and neutrophils, orchestrate the immune response by presenting antigens, secreting cytokines, and producing antigen-binding antibodies (Figure <xref ref-type="fig" rid="F1">1</xref>). In the intestinal epithelium where lymphoid follicles are found, M cells are present that transcytose antigens across the intestinal epithelium to the Peyer’s patches underneath (<xref ref-type="bibr" rid="B14">14</xref>). In addition, goblet cells present acquired luminal antigens to CD103<sup>+</sup> DCs in lamina propria in small intestine by forming goblet cell-associated antigen passages (GAPs) (<xref ref-type="bibr" rid="B32">32</xref>, <xref ref-type="bibr" rid="B33">33</xref>). Interestingly, spontaneous antigen presentation was also observed in the colon, but only when the mice were raised germ-free (GF), or housed conventionally but with oral antibiotic treatment (<xref ref-type="bibr" rid="B34">34</xref>). This suggests that the antigen uptake process and formation of GAPs are regulated by the colonic microbiota (<xref ref-type="bibr" rid="B35">35</xref>). In addition, goblet cells and GAPs are capable of sensing invasive pathogens and inhibiting the translocation of pathogenic bacteria into the host immune system (<xref ref-type="bibr" rid="B36">36</xref>). Furthermore, intestinal mononuclear phagocytescan sense and sample luminal contents (<xref ref-type="bibr" rid="B37">37</xref>, <xref ref-type="bibr" rid="B38">38</xref>). CX3CR1-expressing cells are responsible for this process, and antigen sampling is dependent on structures called transepithelial dendrites (TEDs) (<xref ref-type="bibr" rid="B39">39</xref>, <xref ref-type="bibr" rid="B40">40</xref>). The formation of TEDs is regulated by CX3CR1<sup>+</sup> macrophages and the expression of CX3CL1 by certain IECs (<xref ref-type="bibr" rid="B41">41</xref>, <xref ref-type="bibr" rid="B42">42</xref>).</p>
<p>Another component of the immunological barrier is secretory IgA (SIgA). As the most abundant immunoglobulin in the body, IgA resides primarily on intestinal mucosal surfaces. While some people with selective IgA deficiency appear to be healthy, SIgA is important as it presumably interacts with commensal bacteria to provide protection against pathogens. A unique feature about SIgA is that is structurally resilient in protease-rich environments allowing it to remain functionally active compared to other antibody isotypes on mucosal surfaces (<xref ref-type="bibr" rid="B43">43</xref>). In adult humans, about 50 mg/kg of SIgA is produced daily by plasma cells residing in the intestinal lamina propria. Finally, SIgA can be transcytosed through the epithelium and secreted into the gut lumen.</p>
<p>Though not mentioned here, self-modulating factors, such as nerves and diverse cytokines, are also important for maintaining the normal functions of the intestinal barrier.</p>
</sec>
</sec>
<sec id="S3">
<title>Gut Microbiota and the Intestinal Barrier</title>
<p>Microbiota can be sensed by the host through pattern recognition receptors (PRRs), such as toll-like receptors (TLRs) and nucleotide-binding oligomerization domain (NOD)-like receptors (NLRs). In the gut, the bacteria–host communications are largely dependent on the recognition of microbe-associated molecular patterns by PRRs expressed on immune and non-immune cells. Certain microbiota, bacterial products, and metabolites affect the intestinal barrier function and are responsible for the subsequent breakdown of tissue homeostasis. When there is a leaky gut, commensal bacteria in gut lumen, together with their products, are able to escape the lumen of the gut, which may induce inflammation and cause systemic tissue damages if translocated into peripheral circulation (Figure <xref ref-type="fig" rid="F1">1</xref>). This process of translocation is called microbial translocation (<xref ref-type="bibr" rid="B44">44</xref>).</p>
<p>Evidence from GF animals suggests that the development and function of the intestinal barrier are dependent on microbiota. In GF animals, due to the lack of bacterial stimulations, the thickness of the mucus layers is extremely reduced (<xref ref-type="bibr" rid="B45">45</xref>–<xref ref-type="bibr" rid="B48">48</xref>). The important role of gut microbiota in modulating mucin production from goblet cells is further evidenced in animals with lower loads of bacteria (<xref ref-type="bibr" rid="B49">49</xref>, <xref ref-type="bibr" rid="B50">50</xref>). The thinner mucus layers would allow for bacteria penetration, which may initiate inflammation and inflammatory diseases such as colitis (<xref ref-type="bibr" rid="B46">46</xref>, <xref ref-type="bibr" rid="B51">51</xref>). Commensal bacteria, or bacterial products such as lipopolysaccharide (LPS) and peptidoglycan, can restore the mucus layers (<xref ref-type="bibr" rid="B46">46</xref>, <xref ref-type="bibr" rid="B47">47</xref>). A balance exists between commensal bacteria and the mucus layers, and together they contribute to the maintenance of gut homeostasis (<xref ref-type="bibr" rid="B48">48</xref>). Within the mucus layers, there are diverse secreted AMPs that can clear pathogens and control the colonization of commensal bacteria. Reciprocally, the production of some AMPs is regulated by microbiota and/or their products. For instance, RegIIIγ is the AMP necessary for physically separating commensal bacteria from intestinal epithelium (<xref ref-type="bibr" rid="B11">11</xref>). RegIIIγ has been shown to be suppressed in alcoholic patients and mice receiving ethanol treatment (<xref ref-type="bibr" rid="B52">52</xref>, <xref ref-type="bibr" rid="B53">53</xref>). Prebiotics administration, or increasing probiotic <italic>Lactobacilli</italic> and <italic>Bifidobacteria</italic>, has been shown to restore the properties of RegIIIγ and control bacterial overgrowth (<xref ref-type="bibr" rid="B53">53</xref>). Ang4, a member of angiogenin family, is another example where gut commensals are known to modulate AMP production. In one study, Gordon and coworkers found that the production and secretion of Ang4 from mouse Paneth cells were induced by a predominant gut microflora, <italic>Bacteroides thetaiotaomicron</italic> (<xref ref-type="bibr" rid="B54">54</xref>). Therefore, the antibacterial activity of Ang4 against microbes in gut lumen is, in turn, dependent on the existence of certain commensal species.</p>
<p>In addition, an interaction exists between gut microbes and AMPs, such as IAP. Predominately produced by IECs, IAP is active either anchored on the epithelium membrane or secreted into gut lumen (<xref ref-type="bibr" rid="B55">55</xref>, <xref ref-type="bibr" rid="B56">56</xref>). In IAP-deficient mice, it was noted that there were fewer microbes and an altered bacteria composition compared to control wild-type animals. In particular, the researchers noted a decrease in <italic>Lactobacillaceae</italic> (<xref ref-type="bibr" rid="B57">57</xref>, <xref ref-type="bibr" rid="B58">58</xref>). Upregulated IAP activity can selectively increase LPS-suppressing bacteria (e.g., <italic>Bifidobacterium</italic>), while reducing LPS-producing bacteria (e.g., <italic>Escherichia coli</italic>) (<xref ref-type="bibr" rid="B59">59</xref>). Having the capacity to inactivate LPS <italic>in vivo</italic>, IAP is vital in preventing the translocation of LPS, the pro-inflammatory stimulus originated from bacteria (<xref ref-type="bibr" rid="B60">60</xref>, <xref ref-type="bibr" rid="B61">61</xref>). Of note, the expression of IAP relies on the presence of microbiota. In GF zebrafish, the colonization of commensals, or even supplying LPS alone, could sufficiently induce IAP expression (<xref ref-type="bibr" rid="B62">62</xref>). It is worth mentioning that IAP can also regulate TJ proteins to enhance barrier function through increasing ZO-1, ZO-2, and occludin expression (<xref ref-type="bibr" rid="B63">63</xref>). Several others have also reported on the various types of AMPs and their function in the microbiota (<xref ref-type="bibr" rid="B64">64</xref>, <xref ref-type="bibr" rid="B65">65</xref>).</p>
<p>Intestinal epithelial cells compose the single layer of intestinal epithelium, and the generation of new IECs from local intestinal stem cells is vital in maintaining the barrier function due to the high frequency of apoptosis and shedding of IECs (<xref ref-type="bibr" rid="B66">66</xref>). As much as 10% of all the gene transcriptions, especially genes related to immunity, cell proliferation, and metabolism, in IECs are regulated by gut microbiota (<xref ref-type="bibr" rid="B67">67</xref>). In GF and antibiotic-treated mice, epithelial proliferation rate is reduced, suggesting the role of microbiota on epithelium cell renewal (<xref ref-type="bibr" rid="B68">68</xref>, <xref ref-type="bibr" rid="B69">69</xref>). LPS from <italic>E. coli</italic> can induce cell shedding in a dose-dependent manner (<xref ref-type="bibr" rid="B70">70</xref>, <xref ref-type="bibr" rid="B71">71</xref>). Colonization of <italic>Bifidobacterium breve</italic>, or more precisely its surface component, exopolysaccharide, can positively modulate LPS-induced epithelium cell shedding through epithelial MyD88 signaling (<xref ref-type="bibr" rid="B70">70</xref>). The renewal of IECs relies on the activity of intestinal stem cells that are located at the base of crypts and express TLR4, the LPS receptor. TLR4 activation has been demonstrated to inhibit proliferation and promote the apoptosis of Lgr5<sup>+</sup> intestinal stem cells. In mice bearing selective TLR4 deletion in intestinal stem cells, LPS is no longer able to inhibit the renewal of IECs (<xref ref-type="bibr" rid="B72">72</xref>). This process was found to be mediated by the p53-upregulated modulator of apoptosis (PUMA) as TLR4 activation in mice lacking PUMA was unaltered. Apart from LPS, bacterial metabolites, particularly butyrate, have also been identified as inhibitors of intestinal stem cell proliferation (<xref ref-type="bibr" rid="B73">73</xref>). The intestinal crypt architecture protects the intestinal stem cells from the negative effect of butyrate. As gatekeepers for the paracellular pathway, TJ complexes are also major targets of microbiota regulation (<xref ref-type="bibr" rid="B74">74</xref>). This is particularly true for certain probiotic species including, but not limited to, <italic>Lactobacillus rhamnosus</italic> (<xref ref-type="bibr" rid="B75">75</xref>–<xref ref-type="bibr" rid="B78">78</xref>), <italic>Streptococcus thermophilus</italic> (<xref ref-type="bibr" rid="B79">79</xref>), <italic>Lactobacillus reuteri</italic> (<xref ref-type="bibr" rid="B80">80</xref>), and <italic>Bifidobacterium infantis</italic> (<xref ref-type="bibr" rid="B81">81</xref>).</p>
</sec>
<sec id="S4">
<title>Mechanisms of Leaky Gut</title>
<p>A large variety of gut barrier disruptors and/or gut microbiota disturbers may potentially result in microbial translocation and subsequent inflammation locally and systemically. These include diet, infections, alcohol consumption, and burn injury.</p>
<sec id="S4-1">
<title>Diet-Induced Gut Leakiness</title>
<p>Nutrients and food ingredients have been reported to contribute to the maintenance or alterations of gut microbiota and the intestinal barrier function (<xref ref-type="bibr" rid="B82">82</xref>). A recent review by De Santis et al. detailed many dietary factors that may modulate the intestinal barrier (<xref ref-type="bibr" rid="B83">83</xref>). Here, we review some recent publications and emphasize the effects of diet-induced alterations of gut microbiota on compromising the gut barrier function. Vitamin D (VD) has been recognized as an intestinal permeability protector by inducing the expression of TJ proteins ZO-1 and claudin-1. In VD receptor (VDR)-knockout mice, more severe experimental colitis has been observed, suggesting the protective effect of VD on the mucosal barrier (<xref ref-type="bibr" rid="B84">84</xref>). However, another group have recently found that VDR deficiency lowers, whereas VD treatment upregulates, the expression of claudin-2, a pore-forming TJ protein, which renders the intestinal epithelium leaky (<xref ref-type="bibr" rid="B85">85</xref>). Further analysis confirmed that VDR enhanced claudin-2 promoter activity. The exact role of VD and VDR on modulating intestinal permeability is therefore unclear and should be investigated carefully in association with gut microbiota. In a recent study by Desai et al., a low-fiber diet consumption was found to trigger the expansion of mucus-degrading bacteria, including <italic>Akkermansia muciniphila</italic> and <italic>Bacteroides caccae</italic> (<xref ref-type="bibr" rid="B45">45</xref>). As a result, the thickness of mucus is significantly decreased in mice fed with fiber-deficient diets, although the transcription of <italic>Muc2</italic> gene was surprisingly heightened, possibly as a compensatory response. The thinner mucus and compromised intestinal barrier function lead to a higher susceptibility to certain colitis-causing pathogens (<xref ref-type="bibr" rid="B45">45</xref>). Moreover, a diet high in saturated fat has been shown to greatly decrease <italic>Lactobacillus</italic> and increase <italic>Oscillibacter</italic>, and these changes were correlated with significantly increased permeability in the proximal colon (<xref ref-type="bibr" rid="B86">86</xref>). Furthermore, studies revealed that the abundance of the <italic>Oscillospira</italic> genus was negatively correlated with the mRNA expression of barrier-forming TJ protein ZO-1.</p>
</sec>
<sec id="S4-2">
<title>Stress-Induced Gut Leakiness</title>
<p>Under certain circumstances, stress-induced alterations of gut microbiota and the impaired intestinal barrier would allow the occurrence of microbial translocation. Burn injury and alcohol consumption are examples of such stress. Burn injury results in increased intestinal permeability, which is mediated by increased activity of myosin light-chain (MLC) kinase (<xref ref-type="bibr" rid="B87">87</xref>, <xref ref-type="bibr" rid="B88">88</xref>). It is known that MLC phosphorylation or kinase activation can trigger epithelial TJ opening (<xref ref-type="bibr" rid="B89">89</xref>–<xref ref-type="bibr" rid="B91">91</xref>). In burn injury, TJ proteins, including ZO-1, occluding, and claudin-1, are redistributed, which can be reversed by adding an MLC phosphorylation inhibitor (<xref ref-type="bibr" rid="B87">87</xref>). In addition, both humans and mice experiencing burn injury undergo similar alterations of gut microbiota, in particular, with increases of the abundance of bacteria from the <italic>Enterobacteriaceae</italic> family (<xref ref-type="bibr" rid="B88">88</xref>). Importantly, microbial translocation of these Gram-negative aerobic bacteria has been observed. Another research group, using a different burn injury mouse model reported increased colonic permeability together with reduced aerobic and anaerobic bacterial populations in the gut microbiota, particularly those producing butyrate (<xref ref-type="bibr" rid="B92">92</xref>). As a consequence, the butyrate level in the stool was significantly decreased in mice with burn injury. Interestingly, when the experimental mice received fecal microbiota transplant, their altered bacterial counts and impaired mucosal barrier function were reversed, suggesting direct involvement of microbiota in causing gut leakiness after burn injury.</p>
<p>Chronic alcohol consumption is responsible for intestinal barrier dysfunction, alterations on both the quality and quantity of gut microbiota, LPS translocation, and alcoholic liver disease (ALD). In both human and mouse, it has been well established that alcohol can disrupt intestinal barrier function, which is closely related to increased tumor necrosis factor (TNF) production from intestinal monocytes/macrophages and enterocytes bearing TNF-receptor 1, followed by downstream activation of MLC kinase (<xref ref-type="bibr" rid="B93">93</xref>). Notably, when mice given chronic alcohol also received oral antibiotic treatment, to remove the microbiota, the level of TNF production and intestinal permeability decreased to levels comparable to those in control mice (<xref ref-type="bibr" rid="B93">93</xref>). This indicates that the alcohol-induced, TNF-mediated gut leakiness is greatly dependent on gut microbiota. Indeed, though the mechanism is unknown, alcohol administration alters microbiota qualitatively and quantitatively in both human and mouse (<xref ref-type="bibr" rid="B94">94</xref>). Bacterial overgrowth has been observed with alcohol consumption, whereas antibiotics can decrease the bacterial load and attenuate ALD (<xref ref-type="bibr" rid="B53">53</xref>, <xref ref-type="bibr" rid="B93">93</xref>, <xref ref-type="bibr" rid="B95">95</xref>–<xref ref-type="bibr" rid="B97">97</xref>). Interestingly, probiotic <italic>Lactobacillus</italic> is significantly suppressed during alcohol consumption (<xref ref-type="bibr" rid="B53">53</xref>, <xref ref-type="bibr" rid="B97">97</xref>). Directly supplying <italic>Lactobacillus</italic> strains or indirect stimulation of <italic>Lactobacilli</italic> with prebiotics or diets can decrease bacterial overgrowth, restore mucosal integrity of the intestine, and suppress microbial translocation (<xref ref-type="bibr" rid="B53">53</xref>, <xref ref-type="bibr" rid="B94">94</xref>, <xref ref-type="bibr" rid="B98">98</xref>, <xref ref-type="bibr" rid="B99">99</xref>). Microbial translocation, especially the translocation of LPS, is involved in ALD development and progression as evidenced by the lack of ALD in mice deficient of TLR4 (<xref ref-type="bibr" rid="B100">100</xref>, <xref ref-type="bibr" rid="B101">101</xref>). It is worth noting that some bacteria species can produce alcohol, including <italic>E. coli</italic> and <italic>Weissella confusa</italic>, and this may be the mechanism by which they compromise the intestinal barrier function (<xref ref-type="bibr" rid="B102">102</xref>, <xref ref-type="bibr" rid="B103">103</xref>).</p>
<p>Infections can play a role in regulating the mucosal barrier. A good example is <italic>Helicobacter pylori</italic>, a Gram-negative bacterium infecting the human stomach (<xref ref-type="bibr" rid="B104">104</xref>). <italic>H. pylori</italic> is known to directly increase epithelial permeability by redistributing TJ protein ZO-1 (<xref ref-type="bibr" rid="B105">105</xref>, <xref ref-type="bibr" rid="B106">106</xref>). In addition, bacteriophages, which are usually not considered pathogenic to mammals, can have an impact on the leaky gut. When rats were given a bacteriophage cocktail containing phages against <italic>Salmonella enterica</italic>, disruption of the intestinal barrier integrity was observed (<xref ref-type="bibr" rid="B107">107</xref>). The authors speculated that the gut microbiota might have been affected by bacteriophages, but sequencing data were not supplied to support their claims.</p>
<p>Taken together, perturbation of gut microbiota, which may be the consequence of diverse interventions, can lead to increased intestinal permeability and translocation of bacterial components and products. Such microbial translocation can subsequently trigger an abnormal immune response, causing inflammation and/or tissue damage in extraintestinal organs.</p>
</sec>
</sec>
<sec id="S5">
<title>Leaky Gut and Autoimmune Disorders</title>
<p>Several disease states have been associated with gut microbiota dysbiosis, intestinal barrier dysfunction, and microbial translocation. These include Alzheimer’s disease, ALD, cancer, and multiple autoimmune disorders. Autoimmune disorders are characterized by the generation of autoantibodies against self-antigens that attack the body’s own tissues, resulting in damage. Genetic and environmental triggers have been long known as the major contributors to the development of autoimmunity. Increasing evidence in recent years suggests that microbial translocation and intestinal barrier dysfunction, which may be affected by gut microbiota, are another important causative element for autoimmune disorders (<xref ref-type="bibr" rid="B2">2</xref>–<xref ref-type="bibr" rid="B6">6</xref>). T1D and SLE are examples discussed below that reveal advancements in the understanding of the mechanisms behind the interaction between the leaky gut and autoimmune disorders.</p>
<sec id="S5-1">
<title>Type 1 Diabetes</title>
<p>Type 1 diabetes is an organ-specific autoimmune disorder characterized by an autoimmune response against the host’s own pancreatic β cells, leading to insufficient insulin production from the pancreas (<xref ref-type="bibr" rid="B108">108</xref>). Some argue that the leaky gut is only an outcome of disease progression rather than an initiator or exacerbator of disease (<xref ref-type="bibr" rid="B109">109</xref>), but this should not be the case for T1D. This is supported by the following evidences. First, studies utilizing human subjects affected by T1D or T1D-prone animal models have indicated that impaired intestinal barrier function occurs before disease onset (<xref ref-type="bibr" rid="B110">110</xref>–<xref ref-type="bibr" rid="B112">112</xref>). Second, the pathogenic role that increased intestinal permeability plays in T1D is zonulin-dependent, and the production of zonulin relies on bacterial colonization (<xref ref-type="bibr" rid="B113">113</xref>). Reversion of intestinal barrier dysbiosis by adding a zonulin inhibitor ameliorated T1D manifestations in disease-prone rats (<xref ref-type="bibr" rid="B114">114</xref>). Third, a recent study has provided evidence that microbial translocation contributes to T1D development (<xref ref-type="bibr" rid="B115">115</xref>). In streptozotocin-induced T1D, mice treated with streptozotocin harbor a distinct microbiota compared to vehicle-treated controls. Importantly, gut bacteria were shown to be able to translocate into pancreatic lymph nodes (PLNs) and contribute to T1D development (<xref ref-type="bibr" rid="B115">115</xref>). When mice were treated with oral antibiotics, PLNs appeared to be sterile and the disease was attenuated. Further analysis revealed that the translocated bacteria in PLNs triggered NOD2 activation and exacerbated T1D. Altogether, these results suggest an essential role for the leaky gut in driving the progression of T1D.</p>
</sec>
<sec id="S5-2">
<title>Systemic Lupus Erythematosus</title>
<p>Systemic lupus erythematosus, or lupus, is an autoimmune disorder characterized by severe and persistent inflammation that leads to tissue damage in multiple organs (<xref ref-type="bibr" rid="B116">116</xref>). Although SLE affects both men and women, women of childbearing age are diagnosed about nine times more often than men. LPS, a cell wall component of Gram-negative bacteria, can promote SLE development and disease progression upon penetration of the intestinal epithelium and translocation into tissues (<xref ref-type="bibr" rid="B117">117</xref>). In SLE patients, the higher level of soluble CD14 suggests an increase in LPS, as soluble CD14 is released from monocytes when the cells are exposed to LPS (<xref ref-type="bibr" rid="B118">118</xref>). Activation of TLR4 exacerbates lupus development (<xref ref-type="bibr" rid="B119">119</xref>–<xref ref-type="bibr" rid="B121">121</xref>). Mice spontaneously develop lupus when TLR4 responsiveness is increased, whereas the exacerbated disease phenotype can be significantly ameliorated when the commensal gut flora is removed by antibiotic treatment (<xref ref-type="bibr" rid="B121">121</xref>). This clearly indicates that TLR4 hyperresponsiveness to gut flora (which contains LPS) contributes to the pathogenesis of SLE. Moreover, the development of lupus in wild-type mice (C57BL/6 or BALB/c) immunized with phospholipid-binding proteins can be facilitated by the administration of LPS (<xref ref-type="bibr" rid="B122">122</xref>–<xref ref-type="bibr" rid="B124">124</xref>). Conversely, inhibition of TLR4 results in reduced autoantibody production and lowered renal glomerular IgG deposits in lupus-prone mice (<xref ref-type="bibr" rid="B125">125</xref>, <xref ref-type="bibr" rid="B126">126</xref>). Taken together, these data suggest that LPS stimulation and TLR4 activation as disease-initiating factors for SLE. Lipoteichoic acid (LTA), a component of the Gram-positive bacterial cell wall, can also promote lupus disease. The expression of TLR2, the receptor of LTA, has been reported to be increased in SLE patients (<xref ref-type="bibr" rid="B127">127</xref>). In lupus-prone mice, TLR2 activation triggers lupus nephritis, whereas TLR2 knockout attenuates lupus-like symptoms (<xref ref-type="bibr" rid="B125">125</xref>, <xref ref-type="bibr" rid="B128">128</xref>–<xref ref-type="bibr" rid="B130">130</xref>). Recently, another bacterial antigen that may mimic self-antigens has been recognized to induce autoantibody production (<xref ref-type="bibr" rid="B131">131</xref>).</p>
<p>Several downstream proteins in the TLR signaling cascade are highly relevant to the pathogenesis of SLE and are potential therapeutic targets, including MyD88, IRAKs, and IFNα (<xref ref-type="bibr" rid="B132">132</xref>). Deficiency of MyD88, in particular, has been shown to ameliorate lupus disease in MRL/lpr mice (<xref ref-type="bibr" rid="B133">133</xref>, <xref ref-type="bibr" rid="B134">134</xref>), suggesting a potential role for TLRs to communicate with harmful bacteria in the gut microbiota. Conversely, there is a paucity of data pertaining to members of the NLR family. The most extensively characterized NLRs are associated with inflammasome formation (<xref ref-type="bibr" rid="B135">135</xref>, <xref ref-type="bibr" rid="B136">136</xref>). Loss of NLRP3 and AIM2 inflammasome function was found to significantly contribute to lupus pathogenesis (<xref ref-type="bibr" rid="B137">137</xref>). Interestingly, both of these inflammasomes were found compromised in NZB mice, a lupus-prone model. Consistent with this finding, loss of ASC (apoptosis-associated speck-like protein containing CARD), a common adaptor protein required for inflammasome formation in B6-<italic>Fas<sup>lpr</sup></italic> mice led to exacerbation of lupus-like disease (<xref ref-type="bibr" rid="B138">138</xref>). These results suggest a potential role for NLRs to recognize protective bacteria in the gut microbiota. Therefore, it appears that TLRs and NLRs make distinct contributions to lupus pathogenesis by sensing harmful and protective bacteria, respectively. Both types of bacteria can come from gut microbiota through microbial translocation, especially in the presence of a leaky gut.</p>
</sec>
</sec>
<sec id="S6">
<title>Reversing the Leaky Gut as a Potential Therapy</title>
<p>Considering the contributions of leaky gut and bacterial translocation to inflammation and multiple diseases, reversing gut leakiness appears to be an attractive therapeutic strategy. Prebiotics and probiotics, for example, can be used to reduce intestinal permeability (<xref ref-type="bibr" rid="B139">139</xref>). Diverse probiotic species have been uncovered that possess the properties to protect the intestinal barrier through targeting different components of the mucosal barrier system. The human commensal <italic>Bacteroides fragilis</italic> may serve as such a probiotic (<xref ref-type="bibr" rid="B140">140</xref>). In a mouse model, autism spectrum disorder (ASD) has been shown to be accompanied by intestinal barrier dysfunction, gut microbiota dysbiosis, and leakiness of 4-ethylphenylsulfate (4EPS), which originates from the commensal bacteria. When 4EPS was given to wild-type mice, it directly caused behavioral abnormalities similar to ASD mice. Treatment with <italic>B. fragilis</italic> reduced the translocation of disease-causative 4EPS, and significantly ameliorated the behavior defects. The therapeutic benefit of <italic>B. fragilis</italic> is believed to be due to its ability to alter microbial composition and enhance intestinal barrier function (<xref ref-type="bibr" rid="B140">140</xref>). <italic>B. fragilis</italic> is also known for its capability to induce the development of Foxp3<sup>+</sup> regulatory T cells, a process regulated by another product of <italic>B. fragilis</italic>, polysaccharide A (PSA) (<xref ref-type="bibr" rid="B141">141</xref>, <xref ref-type="bibr" rid="B142">142</xref>). <italic>B. fragilis</italic> and PSA are beneficial against inflammatory diseases, such as colitis and experimental autoimmune encephalomyelitis (<xref ref-type="bibr" rid="B141">141</xref>, <xref ref-type="bibr" rid="B143">143</xref>). The application of <italic>B. fragilis</italic> to prevent the leaky gut and reverse autoimmunity warrants further investigation. In a practical point of view, probiotic candidates with different targets on reversing the leaky gut may synergistically act to attenuate disease as thus may serve as a probiotic cocktail. As probiotics are generally considered safe, it is anticipated that they will become cost-effective treatment options for people with autoimmune diseases in the foreseeable future. This is a very young but exciting field in which much still remains to be learned.</p>
</sec>
<sec id="S7">
<title>Author Contributions</title>
<p>All authors listed have made substantial, direct, and intellectual contribution to the work and approved it for publication.</p>
</sec>
<sec id="S8">
<title>Conflict of Interest Statement</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="financial-disclosure">
<p><bold>Funding.</bold> Preparation of this publication was supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under Award Number R03AI117597. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peterson</surname><given-names>LW</given-names></name><name><surname>Artis</surname><given-names>D</given-names></name></person-group>. <article-title>Intestinal epithelial cells: regulators of barrier function and immune homeostasis</article-title>. <source/>Nat Rev Immunol (<year>2014</year>) <volume>14</volume>(<issue>3</issue>):<fpage>141</fpage>–<lpage>53</lpage>.<pub-id pub-id-type="doi">10.1038/nri3608</pub-id><pub-id pub-id-type="pmid">24566914</pub-id></mixed-citation>
</ref>
<ref id="B2">
<label>2</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>R</given-names></name><name><surname>Zhou</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>B</given-names></name></person-group>. <article-title>Abnormal intestinal permeability and microbiota in patients with autoimmune hepatitis</article-title>. <source/>Int J Clin Exp Pathol (<year>2015</year>) <volume>8</volume>(<issue>5</issue>):<fpage>5153</fpage>–<lpage>60</lpage>.<pub-id pub-id-type="pmid">26191211</pub-id></mixed-citation>
</ref>
<ref id="B3">
<label>3</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khaleghi</surname><given-names>S</given-names></name><name><surname>Ju</surname><given-names>JM</given-names></name><name><surname>Lamba</surname><given-names>A</given-names></name><name><surname>Murray</surname><given-names>JA</given-names></name></person-group>. <article-title>The potential utility of tight junction regulation in celiac disease: focus on larazotide acetate</article-title>. <source/>Therap Adv Gastroenterol (<year>2016</year>) <volume>9</volume>(<issue>1</issue>):<fpage>37</fpage>–<lpage>49</lpage>.<pub-id pub-id-type="doi">10.1177/1756283X15616576</pub-id><pub-id pub-id-type="pmid">26770266</pub-id></mixed-citation>
</ref>
<ref id="B4">
<label>4</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fasano</surname><given-names>A</given-names></name><name><surname>Shea-Donohue</surname><given-names>T</given-names></name></person-group>. <article-title>Mechanisms of disease: the role of intestinal barrier function in the pathogenesis of gastrointestinal autoimmune diseases</article-title>. <source/>Nat Clin Pract Gastroenterol Hepatol (<year>2005</year>) <volume>2</volume>(<issue>9</issue>):<fpage>416</fpage>–<lpage>22</lpage>.<pub-id pub-id-type="doi">10.1038/ncpgasthep0259</pub-id><pub-id pub-id-type="pmid">16265432</pub-id></mixed-citation>
</ref>
<ref id="B5">
<label>5</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tlaskalova-Hogenova</surname><given-names>H</given-names></name><name><surname>Stepankova</surname><given-names>R</given-names></name><name><surname>Kozakova</surname><given-names>H</given-names></name><name><surname>Hudcovic</surname><given-names>T</given-names></name><name><surname>Vannucci</surname><given-names>L</given-names></name><name><surname>Tuckova</surname><given-names>L</given-names></name><etal></etal></person-group>
<article-title>The role of gut microbiota (commensal bacteria) and the mucosal barrier in the pathogenesis of inflammatory and autoimmune diseases and cancer: contribution of germ-free and gnotobiotic animal models of human diseases</article-title>. <source/>Cell Mol Immunol (<year>2011</year>) <volume>8</volume>(<issue>2</issue>):<fpage>110</fpage>–<lpage>20</lpage>.<pub-id pub-id-type="doi">10.1038/cmi.2010.67</pub-id><pub-id pub-id-type="pmid">21278760</pub-id></mixed-citation>
</ref>
<ref id="B6">
<label>6</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fasano</surname><given-names>A</given-names></name></person-group>. <article-title>Zonulin, regulation of tight junctions, and autoimmune diseases</article-title>. <source/>Ann N Y Acad Sci (<year>2012</year>) <volume>1258</volume>:<fpage>25</fpage>–<lpage>33</lpage>.<pub-id pub-id-type="doi">10.1111/j.1749-6632.2012.06538.x</pub-id><pub-id pub-id-type="pmid">22731712</pub-id></mixed-citation>
</ref>
<ref id="B7">
<label>7</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jiminez</surname><given-names>JA</given-names></name><name><surname>Uwiera</surname><given-names>TC</given-names></name><name><surname>Douglas Inglis</surname><given-names>G</given-names></name><name><surname>Uwiera</surname><given-names>RR</given-names></name></person-group>. <article-title>Animal models to study acute and chronic intestinal inflammation in mammals</article-title>. <source/>Gut Pathog (<year>2015</year>) <volume>7</volume>:<fpage>29</fpage>.<pub-id pub-id-type="doi">10.1186/s13099-015-0076-y</pub-id><pub-id pub-id-type="pmid">26561503</pub-id></mixed-citation>
</ref>
<ref id="B8">
<label>8</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brugman</surname><given-names>S</given-names></name></person-group>. <article-title>The zebrafish as a model to study intestinal inflammation</article-title>. <source/>Dev Comp Immunol (<year>2016</year>) <volume>64</volume>:<fpage>82</fpage>–<lpage>92</lpage>.<pub-id pub-id-type="doi">10.1016/j.dci.2016.02.020</pub-id><pub-id pub-id-type="pmid">26902932</pub-id></mixed-citation>
</ref>
<ref id="B9">
<label>9</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hooper</surname><given-names>LV</given-names></name><name><surname>Littman</surname><given-names>DR</given-names></name><name><surname>Macpherson</surname><given-names>AJ</given-names></name></person-group>. <article-title>Interactions between the microbiota and the immune system</article-title>. <source/>Science (<year>2012</year>) <volume>336</volume>(<issue>6086</issue>):<fpage>1268</fpage>–<lpage>73</lpage>.<pub-id pub-id-type="doi">10.1126/science.1223490</pub-id><pub-id pub-id-type="pmid">22674334</pub-id></mixed-citation>
</ref>
<ref id="B10">
<label>10</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gerbe</surname><given-names>F</given-names></name><name><surname>Legraverend</surname><given-names>C</given-names></name><name><surname>Jay</surname><given-names>P</given-names></name></person-group>. <article-title>The intestinal epithelium tuft cells: specification and function</article-title>. <source/>Cell Mol Life Sci (<year>2012</year>) <volume>69</volume>(<issue>17</issue>):<fpage>2907</fpage>–<lpage>17</lpage>.<pub-id pub-id-type="doi">10.1007/s00018-012-0984-7</pub-id><pub-id pub-id-type="pmid">22527717</pub-id></mixed-citation>
</ref>
<ref id="B11">
<label>11</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vaishnava</surname><given-names>S</given-names></name><name><surname>Yamamoto</surname><given-names>M</given-names></name><name><surname>Severson</surname><given-names>KM</given-names></name><name><surname>Ruhn</surname><given-names>KA</given-names></name><name><surname>Yu</surname><given-names>X</given-names></name><name><surname>Koren</surname><given-names>O</given-names></name><etal></etal></person-group>
<article-title>The antibacterial lectin RegIIIgamma promotes the spatial segregation of microbiota and host in the intestine</article-title>. <source/>Science (<year>2011</year>) <volume>334</volume>(<issue>6053</issue>):<fpage>255</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1126/science.1209791</pub-id><pub-id pub-id-type="pmid">21998396</pub-id></mixed-citation>
</ref>
<ref id="B12">
<label>12</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cash</surname><given-names>HL</given-names></name><name><surname>Whitham</surname><given-names>CV</given-names></name><name><surname>Behrendt</surname><given-names>CL</given-names></name><name><surname>Hooper</surname><given-names>LV</given-names></name></person-group>. <article-title>Symbiotic bacteria direct expression of an intestinal bactericidal lectin</article-title>. <source/>Science (<year>2006</year>) <volume>313</volume>(<issue>5790</issue>):<fpage>1126</fpage>–<lpage>30</lpage>.<pub-id pub-id-type="doi">10.1126/science.1127119</pub-id><pub-id pub-id-type="pmid">16931762</pub-id></mixed-citation>
</ref>
<ref id="B13">
<label>13</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vaishnava</surname><given-names>S</given-names></name><name><surname>Behrendt</surname><given-names>CL</given-names></name><name><surname>Ismail</surname><given-names>AS</given-names></name><name><surname>Eckmann</surname><given-names>L</given-names></name><name><surname>Hooper</surname><given-names>LV</given-names></name></person-group>. <article-title>Paneth cells directly sense gut commensals and maintain homeostasis at the intestinal host-microbial interface</article-title>. <source/>Proc Natl Acad Sci U S A (<year>2008</year>) <volume>105</volume>(<issue>52</issue>):<fpage>20858</fpage>–<lpage>63</lpage>.<pub-id pub-id-type="doi">10.1073/pnas.0808723105</pub-id><pub-id pub-id-type="pmid">19075245</pub-id></mixed-citation>
</ref>
<ref id="B14">
<label>14</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mabbott</surname><given-names>NA</given-names></name><name><surname>Donaldson</surname><given-names>DS</given-names></name><name><surname>Ohno</surname><given-names>H</given-names></name><name><surname>Williams</surname><given-names>IR</given-names></name><name><surname>Mahajan</surname><given-names>A</given-names></name></person-group>. <article-title>Microfold (M) cells: important immunosurveillance posts in the intestinal epithelium</article-title>. <source/>Mucosal Immunol (<year>2013</year>) <volume>6</volume>(<issue>4</issue>):<fpage>666</fpage>–<lpage>77</lpage>.<pub-id pub-id-type="doi">10.1038/mi.2013.30</pub-id><pub-id pub-id-type="pmid">23695511</pub-id></mixed-citation>
</ref>
<ref id="B15">
<label>15</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van der Flier</surname><given-names>LG</given-names></name><name><surname>Clevers</surname><given-names>H</given-names></name></person-group>
<article-title>Stem cells, self-renewal, and differentiation in the intestinal epithelium</article-title>. <source/>Annu Rev Physiol (<year>2009</year>) <volume>71</volume>:<fpage>241</fpage>–<lpage>60</lpage>.<pub-id pub-id-type="doi">10.1146/annurev.physiol.010908.163145</pub-id><pub-id pub-id-type="pmid">18808327</pub-id></mixed-citation>
</ref>
<ref id="B16">
<label>16</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anderson</surname><given-names>JM</given-names></name><name><surname>Van Itallie</surname><given-names>CM</given-names></name></person-group>
<article-title>Physiology and function of the tight junction</article-title>. <source/>Cold Spring Harb Perspect Biol (<year>2009</year>) <volume>1</volume>(<issue>2</issue>):<fpage>a002584</fpage><pub-id pub-id-type="doi">10.1101/cshperspect.a002584</pub-id><pub-id pub-id-type="pmid">20066090</pub-id></mixed-citation>
</ref>
<ref id="B17">
<label>17</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yamazaki</surname><given-names>Y</given-names></name><name><surname>Okawa</surname><given-names>K</given-names></name><name><surname>Yano</surname><given-names>T</given-names></name><name><surname>Tsukita</surname><given-names>S</given-names></name><name><surname>Tsukita</surname><given-names>S</given-names></name></person-group>. <article-title>Optimized proteomic analysis on gels of cell-cell adhering junctional membrane proteins</article-title>. <source/>Biochemistry (<year>2008</year>) <volume>47</volume>(<issue>19</issue>):<fpage>5378</fpage>–<lpage>86</lpage>.<pub-id pub-id-type="doi">10.1021/bi8002567</pub-id><pub-id pub-id-type="pmid">18416558</pub-id></mixed-citation>
</ref>
<ref id="B18">
<label>18</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Singh</surname><given-names>PK</given-names></name><name><surname>Parsek</surname><given-names>MR</given-names></name><name><surname>Greenberg</surname><given-names>EP</given-names></name><name><surname>Welsh</surname><given-names>MJ</given-names></name></person-group>. <article-title>A component of innate immunity prevents bacterial biofilm development</article-title>. <source/>Nature (<year>2002</year>) <volume>417</volume>(<issue>6888</issue>):<fpage>552</fpage>–<lpage>5</lpage>.<pub-id pub-id-type="doi">10.1038/417552a</pub-id><pub-id pub-id-type="pmid">12037568</pub-id></mixed-citation>
</ref>
<ref id="B19">
<label>19</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hansson</surname><given-names>GC</given-names></name></person-group>. <article-title>Role of mucus layers in gut infection and inflammation</article-title>. <source/>Curr Opin Microbiol (<year>2012</year>) <volume>15</volume>(<issue>1</issue>):<fpage>57</fpage>–<lpage>62</lpage>.<pub-id pub-id-type="doi">10.1016/j.mib.2011.11.002</pub-id><pub-id pub-id-type="pmid">22177113</pub-id></mixed-citation>
</ref>
<ref id="B20">
<label>20</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pelaseyed</surname><given-names>T</given-names></name><name><surname>Bergstrom</surname><given-names>JH</given-names></name><name><surname>Gustafsson</surname><given-names>JK</given-names></name><name><surname>Ermund</surname><given-names>A</given-names></name><name><surname>Birchenough</surname><given-names>GM</given-names></name><name><surname>Schutte</surname><given-names>A</given-names></name><etal></etal></person-group>
<article-title>The mucus and mucins of the goblet cells and enterocytes provide the first defense line of the gastrointestinal tract and interact with the immune system</article-title>. <source/>Immunol Rev (<year>2014</year>) <volume>260</volume>(<issue>1</issue>):<fpage>8</fpage>–<lpage>20</lpage>.<pub-id pub-id-type="doi">10.1111/imr.12182</pub-id><pub-id pub-id-type="pmid">24942678</pub-id></mixed-citation>
</ref>
<ref id="B21">
<label>21</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van der Sluis</surname><given-names>M</given-names></name><name><surname>De Koning</surname><given-names>BA</given-names></name><name><surname>De Bruijn</surname><given-names>AC</given-names></name><name><surname>Velcich</surname><given-names>A</given-names></name><name><surname>Meijerink</surname><given-names>JP</given-names></name><name><surname>Van Goudoever</surname><given-names>JB</given-names></name><etal></etal></person-group>
<article-title>Muc2-deficient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic protection</article-title>. <source/>Gastroenterology (<year>2006</year>) <volume>131</volume>(<issue>1</issue>):<fpage>117</fpage>–<lpage>29</lpage>.<pub-id pub-id-type="doi">10.1053/j.gastro.2006.04.020</pub-id><pub-id pub-id-type="pmid">16831596</pub-id></mixed-citation>
</ref>
<ref id="B22">
<label>22</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sekirov</surname><given-names>I</given-names></name><name><surname>Russell</surname><given-names>SL</given-names></name><name><surname>Antunes</surname><given-names>LC</given-names></name><name><surname>Finlay</surname><given-names>BB</given-names></name></person-group>
<article-title>Gut microbiota in health and disease</article-title>. <source/>Physiol Rev (<year>2010</year>) <volume>90</volume>(<issue>3</issue>):<fpage>859</fpage>–<lpage>904</lpage>.<pub-id pub-id-type="doi">10.1152/physrev.00045.2009</pub-id><pub-id pub-id-type="pmid">20664075</pub-id></mixed-citation>
</ref>
<ref id="B23">
<label>23</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baumler</surname><given-names>AJ</given-names></name><name><surname>Sperandio</surname><given-names>V</given-names></name></person-group>. <article-title>Interactions between the microbiota and pathogenic bacteria in the gut</article-title>. <source/>Nature (<year>2016</year>) <volume>535</volume>(<issue>7610</issue>):<fpage>85</fpage>–<lpage>93</lpage>.<pub-id pub-id-type="doi">10.1038/nature18849</pub-id><pub-id pub-id-type="pmid">27383983</pub-id></mixed-citation>
</ref>
<ref id="B24">
<label>24</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ming</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>Q</given-names></name><name><surname>Yang</surname><given-names>L</given-names></name><name><surname>Huang</surname><given-names>JA</given-names></name></person-group>. <article-title>Comparison of antibacterial effects between antimicrobial peptide and bacteriocins isolated from <italic>Lactobacillus plantarum</italic> on three common pathogenic bacteria</article-title>. <source/>Int J Clin Exp Med (<year>2015</year>) <volume>8</volume>(<issue>4</issue>):<fpage>5806</fpage>–<lpage>11</lpage>.<pub-id pub-id-type="pmid">26131169</pub-id></mixed-citation>
</ref>
<ref id="B25">
<label>25</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramakrishna</surname><given-names>BS</given-names></name></person-group>. <article-title>Role of the gut microbiota in human nutrition and metabolism</article-title>. <source/>J Gastroenterol Hepatol (<year>2013</year>) <volume>28</volume>(<issue>Suppl 4</issue>):<fpage>9</fpage>–<lpage>17</lpage>.<pub-id pub-id-type="doi">10.1111/jgh.12294</pub-id><pub-id pub-id-type="pmid">24251697</pub-id></mixed-citation>
</ref>
<ref id="B26">
<label>26</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krajmalnik-Brown</surname><given-names>R</given-names></name><name><surname>Ilhan</surname><given-names>ZE</given-names></name><name><surname>Kang</surname><given-names>DW</given-names></name><name><surname>DiBaise</surname><given-names>JK</given-names></name></person-group>. <article-title>Effects of gut microbes on nutrient absorption and energy regulation</article-title>. <source/>Nutr Clin Pract (<year>2012</year>) <volume>27</volume>(<issue>2</issue>):<fpage>201</fpage>–<lpage>14</lpage>.<pub-id pub-id-type="doi">10.1177/0884533611436116</pub-id><pub-id pub-id-type="pmid">22367888</pub-id></mixed-citation>
</ref>
<ref id="B27">
<label>27</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dupont</surname><given-names>A</given-names></name><name><surname>Heinbockel</surname><given-names>L</given-names></name><name><surname>Brandenburg</surname><given-names>K</given-names></name><name><surname>Hornef</surname><given-names>MW</given-names></name></person-group>. <article-title>Antimicrobial peptides and the enteric mucus layer act in concert to protect the intestinal mucosa</article-title>. <source/>Gut Microbes (<year>2014</year>) <volume>5</volume>(<issue>6</issue>):<fpage>761</fpage>–<lpage>5</lpage>.<pub-id pub-id-type="doi">10.4161/19490976.2014.972238</pub-id><pub-id pub-id-type="pmid">25483327</pub-id></mixed-citation>
</ref>
<ref id="B28">
<label>28</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mukherjee</surname><given-names>S</given-names></name><name><surname>Hooper</surname><given-names>LV</given-names></name></person-group>. <article-title>Antimicrobial defense of the intestine</article-title>. <source/>Immunity (<year>2015</year>) <volume>42</volume>(<issue>1</issue>):<fpage>28</fpage>–<lpage>39</lpage>.<pub-id pub-id-type="doi">10.1016/j.immuni.2014.12.028</pub-id><pub-id pub-id-type="pmid">25607457</pub-id></mixed-citation>
</ref>
<ref id="B29">
<label>29</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hofmann</surname><given-names>AF</given-names></name><name><surname>Eckmann</surname><given-names>L</given-names></name></person-group>
<article-title>How bile acids confer gut mucosal protection against bacteria</article-title>. <source/>Proc Natl Acad Sci U S A (<year>2006</year>) <volume>103</volume>(<issue>12</issue>):<fpage>4333</fpage>–<lpage>4</lpage>.<pub-id pub-id-type="doi">10.1073/pnas.0600780103</pub-id><pub-id pub-id-type="pmid">16537368</pub-id></mixed-citation>
</ref>
<ref id="B30">
<label>30</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ostaff</surname><given-names>MJ</given-names></name><name><surname>Stange</surname><given-names>EF</given-names></name><name><surname>Wehkamp</surname><given-names>J</given-names></name></person-group>. <article-title>Antimicrobial peptides and gut microbiota in homeostasis and pathology</article-title>. <source/>EMBO Mol Med (<year>2013</year>) <volume>5</volume>(<issue>10</issue>):<fpage>1465</fpage>–<lpage>83</lpage>.<pub-id pub-id-type="doi">10.1002/emmm.201201773</pub-id><pub-id pub-id-type="pmid">24039130</pub-id></mixed-citation>
</ref>
<ref id="B31">
<label>31</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kopp</surname><given-names>ZA</given-names></name><name><surname>Jain</surname><given-names>U</given-names></name><name><surname>Van Limbergen</surname><given-names>J</given-names></name><name><surname>Stadnyk</surname><given-names>AW</given-names></name></person-group>. <article-title>Do antimicrobial peptides and complement collaborate in the intestinal mucosa?</article-title>
<source/>Front Immunol (<year>2015</year>) <volume>6</volume>:<fpage>17</fpage>.<pub-id pub-id-type="doi">10.3389/fimmu.2015.00017</pub-id><pub-id pub-id-type="pmid">25688244</pub-id></mixed-citation>
</ref>
<ref id="B32">
<label>32</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Howe</surname><given-names>SE</given-names></name><name><surname>Lickteig</surname><given-names>DJ</given-names></name><name><surname>Plunkett</surname><given-names>KN</given-names></name><name><surname>Ryerse</surname><given-names>JS</given-names></name><name><surname>Konjufca</surname><given-names>V</given-names></name></person-group>. <article-title>The uptake of soluble and particulate antigens by epithelial cells in the mouse small intestine</article-title>. <source/>PLoS One (<year>2014</year>) <volume>9</volume>(<issue>1</issue>):<fpage>e86656</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pone.0086656</pub-id><pub-id pub-id-type="pmid">24475164</pub-id></mixed-citation>
</ref>
<ref id="B33">
<label>33</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McDole</surname><given-names>JR</given-names></name><name><surname>Wheeler</surname><given-names>LW</given-names></name><name><surname>McDonald</surname><given-names>KG</given-names></name><name><surname>Wang</surname><given-names>B</given-names></name><name><surname>Konjufca</surname><given-names>V</given-names></name><name><surname>Knoop</surname><given-names>KA</given-names></name><etal></etal></person-group>
<article-title>Goblet cells deliver luminal antigen to CD103+ dendritic cells in the small intestine</article-title>. <source/>Nature (<year>2012</year>) <volume>483</volume>(<issue>7389</issue>):<fpage>345</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1038/nature10863</pub-id><pub-id pub-id-type="pmid">22422267</pub-id></mixed-citation>
</ref>
<ref id="B34">
<label>34</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knoop</surname><given-names>KA</given-names></name><name><surname>McDonald</surname><given-names>KG</given-names></name><name><surname>McCrate</surname><given-names>S</given-names></name><name><surname>McDole</surname><given-names>JR</given-names></name><name><surname>Newberry</surname><given-names>RD</given-names></name></person-group>. <article-title>Microbial sensing by goblet cells controls immune surveillance of luminal antigens in the colon</article-title>. <source/>Mucosal Immunol (<year>2015</year>) <volume>8</volume>(<issue>1</issue>):<fpage>198</fpage>–<lpage>210</lpage>.<pub-id pub-id-type="doi">10.1038/mi.2014.58</pub-id><pub-id pub-id-type="pmid">25005358</pub-id></mixed-citation>
</ref>
<ref id="B35">
<label>35</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Birchenough</surname><given-names>GM</given-names></name><name><surname>Johansson</surname><given-names>ME</given-names></name><name><surname>Gustafsson</surname><given-names>JK</given-names></name><name><surname>Bergstrom</surname><given-names>JH</given-names></name><name><surname>Hansson</surname><given-names>GC</given-names></name></person-group>. <article-title>New developments in goblet cell mucus secretion and function</article-title>. <source/>Mucosal Immunol (<year>2015</year>) <volume>8</volume>(<issue>4</issue>):<fpage>712</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1038/mi.2015.32</pub-id><pub-id pub-id-type="pmid">25872481</pub-id></mixed-citation>
</ref>
<ref id="B36">
<label>36</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Knoop</surname><given-names>KA</given-names></name><name><surname>McDonald</surname><given-names>KG</given-names></name><name><surname>Kulkarni</surname><given-names>DH</given-names></name><name><surname>Newberry</surname><given-names>RD</given-names></name></person-group>. <article-title>Antibiotics promote inflammation through the translocation of native commensal colonic bacteria</article-title>. <source/>Gut (<year>2016</year>) <volume>65</volume>(<issue>7</issue>):<fpage>1100</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1136/gutjnl-2014-309059</pub-id><pub-id pub-id-type="pmid">26045138</pub-id></mixed-citation>
</ref>
<ref id="B37">
<label>37</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rescigno</surname><given-names>M</given-names></name><name><surname>Urbano</surname><given-names>M</given-names></name><name><surname>Valzasina</surname><given-names>B</given-names></name><name><surname>Francolini</surname><given-names>M</given-names></name><name><surname>Rotta</surname><given-names>G</given-names></name><name><surname>Bonasio</surname><given-names>R</given-names></name><etal></etal></person-group>
<article-title>Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria</article-title>. <source/>Nat Immunol (<year>2001</year>) <volume>2</volume>(<issue>4</issue>):<fpage>361</fpage>–<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1038/86373</pub-id><pub-id pub-id-type="pmid">11276208</pub-id></mixed-citation>
</ref>
<ref id="B38">
<label>38</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vallon-Eberhard</surname><given-names>A</given-names></name><name><surname>Landsman</surname><given-names>L</given-names></name><name><surname>Yogev</surname><given-names>N</given-names></name><name><surname>Verrier</surname><given-names>B</given-names></name><name><surname>Jung</surname><given-names>S</given-names></name></person-group>. <article-title>Transepithelial pathogen uptake into the small intestinal lamina propria</article-title>. <source/>J Immunol (<year>2006</year>) <volume>176</volume>(<issue>4</issue>):<fpage>2465</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.176.4.2465</pub-id><pub-id pub-id-type="pmid">16456006</pub-id></mixed-citation>
</ref>
<ref id="B39">
<label>39</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diehl</surname><given-names>GE</given-names></name><name><surname>Longman</surname><given-names>RS</given-names></name><name><surname>Zhang</surname><given-names>JX</given-names></name><name><surname>Breart</surname><given-names>B</given-names></name><name><surname>Galan</surname><given-names>C</given-names></name><name><surname>Cuesta</surname><given-names>A</given-names></name><etal></etal></person-group>
<article-title>Microbiota restricts trafficking of bacteria to mesenteric lymph nodes by CX(3)CR1(hi) cells</article-title>. <source/>Nature (<year>2013</year>) <volume>494</volume>(<issue>7435</issue>):<fpage>116</fpage>–<lpage>20</lpage>.<pub-id pub-id-type="doi">10.1038/nature11809</pub-id><pub-id pub-id-type="pmid">23334413</pub-id></mixed-citation>
</ref>
<ref id="B40">
<label>40</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Niess</surname><given-names>JH</given-names></name><name><surname>Brand</surname><given-names>S</given-names></name><name><surname>Gu</surname><given-names>X</given-names></name><name><surname>Landsman</surname><given-names>L</given-names></name><name><surname>Jung</surname><given-names>S</given-names></name><name><surname>McCormick</surname><given-names>BA</given-names></name><etal></etal></person-group>
<article-title>CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance</article-title>. <source/>Science (<year>2005</year>) <volume>307</volume>(<issue>5707</issue>):<fpage>254</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1126/science.1102901</pub-id><pub-id pub-id-type="pmid">15653504</pub-id></mixed-citation>
</ref>
<ref id="B41">
<label>41</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gross</surname><given-names>M</given-names></name><name><surname>Salame</surname><given-names>TM</given-names></name><name><surname>Jung</surname><given-names>S</given-names></name></person-group>. <article-title>Guardians of the gut – murine intestinal macrophages and dendritic cells</article-title>. <source/>Front Immunol (<year>2015</year>) <volume>6</volume>:<fpage>254</fpage>.<pub-id pub-id-type="doi">10.3389/fimmu.2015.00254</pub-id><pub-id pub-id-type="pmid">26082775</pub-id></mixed-citation>
</ref>
<ref id="B42">
<label>42</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>KW</given-names></name><name><surname>Vallon-Eberhard</surname><given-names>A</given-names></name><name><surname>Zigmond</surname><given-names>E</given-names></name><name><surname>Farache</surname><given-names>J</given-names></name><name><surname>Shezen</surname><given-names>E</given-names></name><name><surname>Shakhar</surname><given-names>G</given-names></name><etal></etal></person-group>
<article-title>In vivo structure/function and expression analysis of the CX3C chemokine fractalkine</article-title>. <source/>Blood (<year>2011</year>) <volume>118</volume>(<issue>22</issue>):<fpage>e156</fpage>–<lpage>67</lpage>.<pub-id pub-id-type="doi">10.1182/blood-2011-04-348946</pub-id><pub-id pub-id-type="pmid">21951685</pub-id></mixed-citation>
</ref>
<ref id="B43">
<label>43</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Woof</surname><given-names>JM</given-names></name><name><surname>Russell</surname><given-names>MW</given-names></name></person-group>. <article-title>Structure and function relationships in IgA</article-title>. <source/>Mucosal Immunol (<year>2011</year>) <volume>4</volume>(<issue>6</issue>):<fpage>590</fpage>–<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1038/mi.2011.39</pub-id><pub-id pub-id-type="pmid">21937984</pub-id></mixed-citation>
</ref>
<ref id="B44">
<label>44</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brenchley</surname><given-names>JM</given-names></name><name><surname>Douek</surname><given-names>DC</given-names></name></person-group>. <article-title>Microbial translocation across the GI tract</article-title>. <source/>Annu Rev Immunol (<year>2012</year>) <volume>30</volume>:<fpage>149</fpage>–<lpage>73</lpage>.<pub-id pub-id-type="doi">10.1146/annurev-immunol-020711-075001</pub-id><pub-id pub-id-type="pmid">22224779</pub-id></mixed-citation>
</ref>
<ref id="B45">
<label>45</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Desai</surname><given-names>MS</given-names></name><name><surname>Seekatz</surname><given-names>AM</given-names></name><name><surname>Koropatkin</surname><given-names>NM</given-names></name><name><surname>Kamada</surname><given-names>N</given-names></name><name><surname>Hickey</surname><given-names>CA</given-names></name><name><surname>Wolter</surname><given-names>M</given-names></name><etal></etal></person-group>
<article-title>A dietary fiber-deprived gut microbiota degrades the colonic mucus barrier and enhances pathogen susceptibility</article-title>. <source/>Cell (<year>2016</year>) <volume>167</volume>(<issue>5</issue>):<fpage>1339</fpage>–<lpage>53 e21</lpage>.<pub-id pub-id-type="doi">10.1016/j.cell.2016.10.043</pub-id><pub-id pub-id-type="pmid">27863247</pub-id></mixed-citation>
</ref>
<ref id="B46">
<label>46</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johansson</surname><given-names>ME</given-names></name><name><surname>Jakobsson</surname><given-names>HE</given-names></name><name><surname>Holmen-Larsson</surname><given-names>J</given-names></name><name><surname>Schutte</surname><given-names>A</given-names></name><name><surname>Ermund</surname><given-names>A</given-names></name><name><surname>Rodriguez-Pineiro</surname><given-names>AM</given-names></name><etal></etal></person-group>
<article-title>Normalization of host intestinal mucus layers requires long-term microbial colonization</article-title>. <source/>Cell Host Microbe (<year>2015</year>) <volume>18</volume>(<issue>5</issue>):<fpage>582</fpage>–<lpage>92</lpage>.<pub-id pub-id-type="doi">10.1016/j.chom.2015.10.007</pub-id><pub-id pub-id-type="pmid">26526499</pub-id></mixed-citation>
</ref>
<ref id="B47">
<label>47</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petersson</surname><given-names>J</given-names></name><name><surname>Schreiber</surname><given-names>O</given-names></name><name><surname>Hansson</surname><given-names>GC</given-names></name><name><surname>Gendler</surname><given-names>SJ</given-names></name><name><surname>Velcich</surname><given-names>A</given-names></name><name><surname>Lundberg</surname><given-names>JO</given-names></name><etal></etal></person-group>
<article-title>Importance and regulation of the colonic mucus barrier in a mouse model of colitis</article-title>. <source/>Am J Physiol Gastrointest Liver Physiol (<year>2011</year>) <volume>300</volume>(<issue>2</issue>):<fpage>G327</fpage>–<lpage>33</lpage>.<pub-id pub-id-type="doi">10.1152/ajpgi.00422.2010</pub-id><pub-id pub-id-type="pmid">21109593</pub-id></mixed-citation>
</ref>
<ref id="B48">
<label>48</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wrzosek</surname><given-names>L</given-names></name><name><surname>Miquel</surname><given-names>S</given-names></name><name><surname>Noordine</surname><given-names>ML</given-names></name><name><surname>Bouet</surname><given-names>S</given-names></name><name><surname>Joncquel Chevalier-Curt</surname><given-names>M</given-names></name><name><surname>Robert</surname><given-names>V</given-names></name><etal></etal></person-group>
<article-title><italic>Bacteroides thetaiotaomicron</italic> and <italic>Faecalibacterium prausnitzii</italic> influence the production of mucus glycans and the development of goblet cells in the colonic epithelium of a gnotobiotic model rodent</article-title>. <source/>BMC Biol (<year>2013</year>) <volume>11</volume>:<fpage>61</fpage>.<pub-id pub-id-type="doi">10.1186/1741-7007-11-61</pub-id><pub-id pub-id-type="pmid">23692866</pub-id></mixed-citation>
</ref>
<ref id="B49">
<label>49</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Forder</surname><given-names>RE</given-names></name><name><surname>Howarth</surname><given-names>GS</given-names></name><name><surname>Tivey</surname><given-names>DR</given-names></name><name><surname>Hughes</surname><given-names>RJ</given-names></name></person-group>. <article-title>Bacterial modulation of small intestinal goblet cells and mucin composition during early posthatch development of poultry</article-title>. <source/>Poult Sci (<year>2007</year>) <volume>86</volume>(<issue>11</issue>):<fpage>2396</fpage>–<lpage>403</lpage>.<pub-id pub-id-type="doi">10.3382/ps.2007-00222</pub-id><pub-id pub-id-type="pmid">17954591</pub-id></mixed-citation>
</ref>
<ref id="B50">
<label>50</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wlodarska</surname><given-names>M</given-names></name><name><surname>Willing</surname><given-names>B</given-names></name><name><surname>Keeney</surname><given-names>KM</given-names></name><name><surname>Menendez</surname><given-names>A</given-names></name><name><surname>Bergstrom</surname><given-names>KS</given-names></name><name><surname>Gill</surname><given-names>N</given-names></name><etal></etal></person-group>
<article-title>Antibiotic treatment alters the colonic mucus layer and predisposes the host to exacerbated <italic>Citrobacter rodentium</italic>-induced colitis</article-title>. <source/>Infect Immun (<year>2011</year>) <volume>79</volume>(<issue>4</issue>):<fpage>1536</fpage>–<lpage>45</lpage>.<pub-id pub-id-type="doi">10.1128/IAI.01104-10</pub-id><pub-id pub-id-type="pmid">21321077</pub-id></mixed-citation>
</ref>
<ref id="B51">
<label>51</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johansson</surname><given-names>ME</given-names></name><name><surname>Gustafsson</surname><given-names>JK</given-names></name><name><surname>Sjoberg</surname><given-names>KE</given-names></name><name><surname>Petersson</surname><given-names>J</given-names></name><name><surname>Holm</surname><given-names>L</given-names></name><name><surname>Sjovall</surname><given-names>H</given-names></name><etal></etal></person-group>
<article-title>Bacteria penetrate the inner mucus layer before inflammation in the dextran sulfate colitis model</article-title>. <source/>PLoS One (<year>2010</year>) <volume>5</volume>(<issue>8</issue>):<fpage>e12238</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0012238</pub-id><pub-id pub-id-type="pmid">20805871</pub-id></mixed-citation>
</ref>
<ref id="B52">
<label>52</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Fouts</surname><given-names>DE</given-names></name><name><surname>Starkel</surname><given-names>P</given-names></name><name><surname>Hartmann</surname><given-names>P</given-names></name><name><surname>Chen</surname><given-names>P</given-names></name><name><surname>Llorente</surname><given-names>C</given-names></name><etal></etal></person-group>
<article-title>Intestinal REG3 lectins protect against alcoholic steatohepatitis by reducing mucosa-associated microbiota and preventing bacterial translocation</article-title>. <source/>Cell Host Microbe (<year>2016</year>) <volume>19</volume>(<issue>2</issue>):<fpage>227</fpage>–<lpage>39</lpage>.<pub-id pub-id-type="doi">10.1016/j.chom.2016.01.003</pub-id><pub-id pub-id-type="pmid">26867181</pub-id></mixed-citation>
</ref>
<ref id="B53">
<label>53</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname><given-names>AW</given-names></name><name><surname>Fouts</surname><given-names>DE</given-names></name><name><surname>Brandl</surname><given-names>J</given-names></name><name><surname>Starkel</surname><given-names>P</given-names></name><name><surname>Torralba</surname><given-names>M</given-names></name><name><surname>Schott</surname><given-names>E</given-names></name><etal></etal></person-group>
<article-title>Enteric dysbiosis associated with a mouse model of alcoholic liver disease</article-title>. <source/>Hepatology (<year>2011</year>) <volume>53</volume>(<issue>1</issue>):<fpage>96</fpage>–<lpage>105</lpage>.<pub-id pub-id-type="doi">10.1002/hep.24018</pub-id><pub-id pub-id-type="pmid">21254165</pub-id></mixed-citation>
</ref>
<ref id="B54">
<label>54</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hooper</surname><given-names>LV</given-names></name><name><surname>Stappenbeck</surname><given-names>TS</given-names></name><name><surname>Hong</surname><given-names>CV</given-names></name><name><surname>Gordon</surname><given-names>JI</given-names></name></person-group>. <article-title>Angiogenins: a new class of microbicidal proteins involved in innate immunity</article-title>. <source/>Nat Immunol (<year>2003</year>) <volume>4</volume>(<issue>3</issue>):<fpage>269</fpage>–<lpage>73</lpage>.<pub-id pub-id-type="doi">10.1038/ni888</pub-id><pub-id pub-id-type="pmid">12548285</pub-id></mixed-citation>
</ref>
<ref id="B55">
<label>55</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eliakim</surname><given-names>R</given-names></name><name><surname>Mahmood</surname><given-names>A</given-names></name><name><surname>Alpers</surname><given-names>DH</given-names></name></person-group>. <article-title>Rat intestinal alkaline phosphatase secretion into lumen and serum is coordinately regulated</article-title>. <source/>Biochim Biophys Acta (<year>1991</year>) <volume>1091</volume>(<issue>1</issue>):<fpage>1</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1016/0167-4889(91)90213-H</pub-id><pub-id pub-id-type="pmid">1671644</pub-id></mixed-citation>
</ref>
<ref id="B56">
<label>56</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakano</surname><given-names>T</given-names></name><name><surname>Inoue</surname><given-names>I</given-names></name><name><surname>Alpers</surname><given-names>DH</given-names></name><name><surname>Akiba</surname><given-names>Y</given-names></name><name><surname>Katayama</surname><given-names>S</given-names></name><name><surname>Shinozaki</surname><given-names>R</given-names></name><etal></etal></person-group>
<article-title>Role of lysophosphatidylcholine in brush-border intestinal alkaline phosphatase release and restoration</article-title>. <source/>Am J Physiol Gastrointest Liver Physiol (<year>2009</year>) <volume>297</volume>(<issue>1</issue>):<fpage>G207</fpage>–<lpage>14</lpage>.<pub-id pub-id-type="doi">10.1152/ajpgi.90590.2008</pub-id><pub-id pub-id-type="pmid">19407215</pub-id></mixed-citation>
</ref>
<ref id="B57">
<label>57</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malo</surname><given-names>MS</given-names></name><name><surname>Alam</surname><given-names>SN</given-names></name><name><surname>Mostafa</surname><given-names>G</given-names></name><name><surname>Zeller</surname><given-names>SJ</given-names></name><name><surname>Johnson</surname><given-names>PV</given-names></name><name><surname>Mohammad</surname><given-names>N</given-names></name><etal></etal></person-group>
<article-title>Intestinal alkaline phosphatase preserves the normal homeostasis of gut microbiota</article-title>. <source/>Gut (<year>2010</year>) <volume>59</volume>(<issue>11</issue>):<fpage>1476</fpage>–<lpage>84</lpage>.<pub-id pub-id-type="doi">10.1136/gut.2010.211706</pub-id><pub-id pub-id-type="pmid">20947883</pub-id></mixed-citation>
</ref>
<ref id="B58">
<label>58</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manichanh</surname><given-names>C</given-names></name><name><surname>Rigottier-Gois</surname><given-names>L</given-names></name><name><surname>Bonnaud</surname><given-names>E</given-names></name><name><surname>Gloux</surname><given-names>K</given-names></name><name><surname>Pelletier</surname><given-names>E</given-names></name><name><surname>Frangeul</surname><given-names>L</given-names></name><etal></etal></person-group>
<article-title>Reduced diversity of faecal microbiota in Crohn’s disease revealed by a metagenomic approach</article-title>. <source/>Gut (<year>2006</year>) <volume>55</volume>(<issue>2</issue>):<fpage>205</fpage>–<lpage>11</lpage>.<pub-id pub-id-type="doi">10.1136/gut.2005.073817</pub-id><pub-id pub-id-type="pmid">16188921</pub-id></mixed-citation>
</ref>
<ref id="B59">
<label>59</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaliannan</surname><given-names>K</given-names></name><name><surname>Wang</surname><given-names>B</given-names></name><name><surname>Li</surname><given-names>XY</given-names></name><name><surname>Kim</surname><given-names>KJ</given-names></name><name><surname>Kang</surname><given-names>JX</given-names></name></person-group>. <article-title>A host-microbiome interaction mediates the opposing effects of omega-6 and omega-3 fatty acids on metabolic endotoxemia</article-title>. <source/>Sci Rep (<year>2015</year>) <volume>5</volume>:<fpage>11276</fpage>.<pub-id pub-id-type="doi">10.1038/srep11276</pub-id><pub-id pub-id-type="pmid">26062993</pub-id></mixed-citation>
</ref>
<ref id="B60">
<label>60</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bates</surname><given-names>JM</given-names></name><name><surname>Akerlund</surname><given-names>J</given-names></name><name><surname>Mittge</surname><given-names>E</given-names></name><name><surname>Guillemin</surname><given-names>K</given-names></name></person-group>. <article-title>Intestinal alkaline phosphatase detoxifies lipopolysaccharide and prevents inflammation in zebrafish in response to the gut microbiota</article-title>. <source/>Cell Host Microbe (<year>2007</year>) <volume>2</volume>(<issue>6</issue>):<fpage>371</fpage>–<lpage>82</lpage>.<pub-id pub-id-type="doi">10.1016/j.chom.2007.10.010</pub-id><pub-id pub-id-type="pmid">18078689</pub-id></mixed-citation>
</ref>
<ref id="B61">
<label>61</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Millan</surname><given-names>JL</given-names></name><name><surname>Mecsas</surname><given-names>J</given-names></name><name><surname>Guillemin</surname><given-names>K</given-names></name></person-group>. <article-title>Intestinal alkaline phosphatase deficiency leads to lipopolysaccharide desensitization and faster weight gain</article-title>. <source/>Infect Immun (<year>2015</year>) <volume>83</volume>(<issue>1</issue>):<fpage>247</fpage>–<lpage>58</lpage>.<pub-id pub-id-type="doi">10.1128/IAI.02520-14</pub-id><pub-id pub-id-type="pmid">25348635</pub-id></mixed-citation>
</ref>
<ref id="B62">
<label>62</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bates</surname><given-names>JM</given-names></name><name><surname>Mittge</surname><given-names>E</given-names></name><name><surname>Kuhlman</surname><given-names>J</given-names></name><name><surname>Baden</surname><given-names>KN</given-names></name><name><surname>Cheesman</surname><given-names>SE</given-names></name><name><surname>Guillemin</surname><given-names>K</given-names></name></person-group>. <article-title>Distinct signals from the microbiota promote different aspects of zebrafish gut differentiation</article-title>. <source/>Dev Biol (<year>2006</year>) <volume>297</volume>(<issue>2</issue>):<fpage>374</fpage>–<lpage>86</lpage>.<pub-id pub-id-type="doi">10.1016/j.ydbio.2006.05.006</pub-id><pub-id pub-id-type="pmid">16781702</pub-id></mixed-citation>
</ref>
<ref id="B63">
<label>63</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>W</given-names></name><name><surname>Hu</surname><given-names>D</given-names></name><name><surname>Huo</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Adiliaghdam</surname><given-names>F</given-names></name><name><surname>Morrison</surname><given-names>S</given-names></name><etal></etal></person-group>
<article-title>Intestinal alkaline phosphatase regulates tight junction protein levels</article-title>. <source/>J Am Coll Surg (<year>2016</year>) <volume>222</volume>(<issue>6</issue>):<fpage>1009</fpage>–<lpage>17</lpage>.<pub-id pub-id-type="doi">10.1016/j.jamcollsurg.2015.12.006</pub-id><pub-id pub-id-type="pmid">27106638</pub-id></mixed-citation>
</ref>
<ref id="B64">
<label>64</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bevins</surname><given-names>CL</given-names></name><name><surname>Salzman</surname><given-names>NH</given-names></name></person-group>. <article-title>Paneth cells, antimicrobial peptides and maintenance of intestinal homeostasis</article-title>. <source/>Nat Rev Microbiol (<year>2011</year>) <volume>9</volume>(<issue>5</issue>):<fpage>356</fpage>–<lpage>68</lpage>.<pub-id pub-id-type="doi">10.1038/nrmicro2546</pub-id><pub-id pub-id-type="pmid">21423246</pub-id></mixed-citation>
</ref>
<ref id="B65">
<label>65</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gallo</surname><given-names>RL</given-names></name><name><surname>Hooper</surname><given-names>LV</given-names></name></person-group>. <article-title>Epithelial antimicrobial defence of the skin and intestine</article-title>. <source/>Nat Rev Immunol (<year>2012</year>) <volume>12</volume>(<issue>7</issue>):<fpage>503</fpage>–<lpage>16</lpage>.<pub-id pub-id-type="doi">10.1038/nri3228</pub-id><pub-id pub-id-type="pmid">22728527</pub-id></mixed-citation>
</ref>
<ref id="B66">
<label>66</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>JM</given-names></name><name><surname>Duckworth</surname><given-names>CA</given-names></name><name><surname>Burkitt</surname><given-names>MD</given-names></name><name><surname>Watson</surname><given-names>AJ</given-names></name><name><surname>Campbell</surname><given-names>BJ</given-names></name><name><surname>Pritchard</surname><given-names>DM</given-names></name></person-group>. <article-title>Epithelial cell shedding and barrier function: a matter of life and death at the small intestinal villus tip</article-title>. <source/>Vet Pathol (<year>2015</year>) <volume>52</volume>(<issue>3</issue>):<fpage>445</fpage>–<lpage>55</lpage>.<pub-id pub-id-type="doi">10.1177/0300985814559404</pub-id><pub-id pub-id-type="pmid">25428410</pub-id></mixed-citation>
</ref>
<ref id="B67">
<label>67</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sommer</surname><given-names>F</given-names></name><name><surname>Nookaew</surname><given-names>I</given-names></name><name><surname>Sommer</surname><given-names>N</given-names></name><name><surname>Fogelstrand</surname><given-names>P</given-names></name><name><surname>Backhed</surname><given-names>F</given-names></name></person-group>. <article-title>Site-specific programming of the host epithelial transcriptome by the gut microbiota</article-title>. <source/>Genome Biol (<year>2015</year>) <volume>16</volume>:<fpage>62</fpage>.<pub-id pub-id-type="doi">10.1186/s13059-015-0614-4</pub-id><pub-id pub-id-type="pmid">25887251</pub-id></mixed-citation>
</ref>
<ref id="B68">
<label>68</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reikvam</surname><given-names>DH</given-names></name><name><surname>Erofeev</surname><given-names>A</given-names></name><name><surname>Sandvik</surname><given-names>A</given-names></name><name><surname>Grcic</surname><given-names>V</given-names></name><name><surname>Jahnsen</surname><given-names>FL</given-names></name><name><surname>Gaustad</surname><given-names>P</given-names></name><etal></etal></person-group>
<article-title>Depletion of murine intestinal microbiota: effects on gut mucosa and epithelial gene expression</article-title>. <source/>PLoS One (<year>2011</year>) <volume>6</volume>(<issue>3</issue>):<fpage>e17996</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pone.0017996</pub-id><pub-id pub-id-type="pmid">21445311</pub-id></mixed-citation>
</ref>
<ref id="B69">
<label>69</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stedman</surname><given-names>A</given-names></name><name><surname>Nigro</surname><given-names>G</given-names></name><name><surname>Sansonetti</surname><given-names>PJ</given-names></name></person-group>. <article-title>[Microbiota-intestinal stem cells dialog: a key element for intestinal regeneration]</article-title>. <source/>Med Sci (Paris) (<year>2016</year>) <volume>32</volume>(<issue>11</issue>):<fpage>983</fpage>–<lpage>90</lpage>.<pub-id pub-id-type="doi">10.1051/medsci/20163211014</pub-id><pub-id pub-id-type="pmid">28008839</pub-id></mixed-citation>
</ref>
<ref id="B70">
<label>70</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hughes</surname><given-names>KR</given-names></name><name><surname>Harnisch</surname><given-names>LC</given-names></name><name><surname>Alcon-Giner</surname><given-names>C</given-names></name><name><surname>Mitra</surname><given-names>S</given-names></name><name><surname>Wright</surname><given-names>CJ</given-names></name><name><surname>Ketskemety</surname><given-names>J</given-names></name><etal></etal></person-group>
<article-title><italic>Bifidobacterium breve</italic> reduces apoptotic epithelial cell shedding in an exopolysaccharide and MyD88-dependent manner</article-title>. <source/>Open Biol (<year>2017</year>) <volume>7</volume>(<issue>1</issue>):<fpage>160155</fpage>.<pub-id pub-id-type="doi">10.1098/rsob.160155</pub-id><pub-id pub-id-type="pmid">28123052</pub-id></mixed-citation>
</ref>
<ref id="B71">
<label>71</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Williams</surname><given-names>JM</given-names></name><name><surname>Duckworth</surname><given-names>CA</given-names></name><name><surname>Watson</surname><given-names>AJ</given-names></name><name><surname>Frey</surname><given-names>MR</given-names></name><name><surname>Miguel</surname><given-names>JC</given-names></name><name><surname>Burkitt</surname><given-names>MD</given-names></name><etal></etal></person-group>
<article-title>A mouse model of pathological small intestinal epithelial cell apoptosis and shedding induced by systemic administration of lipopolysaccharide</article-title>. <source/>Dis Model Mech (<year>2013</year>) <volume>6</volume>(<issue>6</issue>):<fpage>1388</fpage>–<lpage>99</lpage>.<pub-id pub-id-type="doi">10.1242/dmm.013284</pub-id><pub-id pub-id-type="pmid">24046352</pub-id></mixed-citation>
</ref>
<ref id="B72">
<label>72</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Neal</surname><given-names>MD</given-names></name><name><surname>Sodhi</surname><given-names>CP</given-names></name><name><surname>Jia</surname><given-names>H</given-names></name><name><surname>Dyer</surname><given-names>M</given-names></name><name><surname>Egan</surname><given-names>CE</given-names></name><name><surname>Yazji</surname><given-names>I</given-names></name><etal></etal></person-group>
<article-title>Toll-like receptor 4 is expressed on intestinal stem cells and regulates their proliferation and apoptosis via the p53 up-regulated modulator of apoptosis</article-title>. <source/>J Biol Chem (<year>2012</year>) <volume>287</volume>(<issue>44</issue>):<fpage>37296</fpage>–<lpage>308</lpage>.<pub-id pub-id-type="doi">10.1074/jbc.M112.375881</pub-id><pub-id pub-id-type="pmid">22955282</pub-id></mixed-citation>
</ref>
<ref id="B73">
<label>73</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaiko</surname><given-names>GE</given-names></name><name><surname>Ryu</surname><given-names>SH</given-names></name><name><surname>Koues</surname><given-names>OI</given-names></name><name><surname>Collins</surname><given-names>PL</given-names></name><name><surname>Solnica-Krezel</surname><given-names>L</given-names></name><name><surname>Pearce</surname><given-names>EJ</given-names></name><etal></etal></person-group>
<article-title>The colonic crypt protects stem cells from microbiota-derived metabolites</article-title>. <source/>Cell (<year>2016</year>) <volume>167</volume>(<issue>4</issue>):<fpage>1137</fpage><pub-id pub-id-type="doi">10.1016/j.cell.2016.10.034</pub-id><pub-id pub-id-type="pmid">27814510</pub-id></mixed-citation>
</ref>
<ref id="B74">
<label>74</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ulluwishewa</surname><given-names>D</given-names></name><name><surname>Anderson</surname><given-names>RC</given-names></name><name><surname>McNabb</surname><given-names>WC</given-names></name><name><surname>Moughan</surname><given-names>PJ</given-names></name><name><surname>Wells</surname><given-names>JM</given-names></name><name><surname>Roy</surname><given-names>NC</given-names></name></person-group>. <article-title>Regulation of tight junction permeability by intestinal bacteria and dietary components</article-title>. <source/>J Nutr (<year>2011</year>) <volume>141</volume>(<issue>5</issue>):<fpage>769</fpage>–<lpage>76</lpage>.<pub-id pub-id-type="doi">10.3945/jn.110.135657</pub-id><pub-id pub-id-type="pmid">21430248</pub-id></mixed-citation>
</ref>
<ref id="B75">
<label>75</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Donato</surname><given-names>KA</given-names></name><name><surname>Gareau</surname><given-names>MG</given-names></name><name><surname>Wang</surname><given-names>YJ</given-names></name><name><surname>Sherman</surname><given-names>PM</given-names></name></person-group>. <article-title><italic>Lactobacillus rhamnosus</italic> GG attenuates interferon-{gamma} and tumour necrosis factor-alpha-induced barrier dysfunction and pro-inflammatory signalling</article-title>. <source/>Microbiology (<year>2010</year>) <volume>156</volume>(<issue>Pt 11</issue>):<fpage>3288</fpage>–<lpage>97</lpage>.<pub-id pub-id-type="doi">10.1099/mic.0.040139-0</pub-id><pub-id pub-id-type="pmid">20656777</pub-id></mixed-citation>
</ref>
<ref id="B76">
<label>76</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Johnson-Henry</surname><given-names>KC</given-names></name><name><surname>Donato</surname><given-names>KA</given-names></name><name><surname>Shen-Tu</surname><given-names>G</given-names></name><name><surname>Gordanpour</surname><given-names>M</given-names></name><name><surname>Sherman</surname><given-names>PM</given-names></name></person-group>. <article-title><italic>Lactobacillus rhamnosus</italic> strain GG prevents enterohemorrhagic <italic>Escherichia coli</italic> O157: H7-induced changes in epithelial barrier function</article-title>. <source/>Infect Immun (<year>2008</year>) <volume>76</volume>(<issue>4</issue>):<fpage>1340</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1128/IAI.00778-07</pub-id><pub-id pub-id-type="pmid">18227169</pub-id></mixed-citation>
</ref>
<ref id="B77">
<label>77</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miyauchi</surname><given-names>E</given-names></name><name><surname>Morita</surname><given-names>H</given-names></name><name><surname>Tanabe</surname><given-names>S</given-names></name></person-group>. <article-title><italic>Lactobacillus rhamnosus</italic> alleviates intestinal barrier dysfunction in part by increasing expression of zonula occludens-1 and myosin light-chain kinase in vivo</article-title>. <source/>J Dairy Sci (<year>2009</year>) <volume>92</volume>(<issue>6</issue>):<fpage>2400</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="doi">10.3168/jds.2008-1698</pub-id><pub-id pub-id-type="pmid">19447972</pub-id></mixed-citation>
</ref>
<ref id="B78">
<label>78</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seth</surname><given-names>A</given-names></name><name><surname>Yan</surname><given-names>F</given-names></name><name><surname>Polk</surname><given-names>DB</given-names></name><name><surname>Rao</surname><given-names>RK</given-names></name></person-group>. <article-title>Probiotics ameliorate the hydrogen peroxide-induced epithelial barrier disruption by a PKC- and MAP kinase-dependent mechanism</article-title>. <source/>Am J Physiol Gastrointest Liver Physiol (<year>2008</year>) <volume>294</volume>(<issue>4</issue>):<fpage>G1060</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1152/ajpgi.00202.2007</pub-id><pub-id pub-id-type="pmid">18292183</pub-id></mixed-citation>
</ref>
<ref id="B79">
<label>79</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Resta-Lenert</surname><given-names>S</given-names></name><name><surname>Barrett</surname><given-names>KE</given-names></name></person-group>. <article-title>Live probiotics protect intestinal epithelial cells from the effects of infection with enteroinvasive <italic>Escherichia coli</italic> (EIEC)</article-title>. <source/>Gut (<year>2003</year>) <volume>52</volume>(<issue>7</issue>):<fpage>988</fpage>–<lpage>97</lpage>.<pub-id pub-id-type="doi">10.1136/gut.52.7.988</pub-id><pub-id pub-id-type="pmid">12801956</pub-id></mixed-citation>
</ref>
<ref id="B80">
<label>80</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ewaschuk</surname><given-names>JB</given-names></name><name><surname>Diaz</surname><given-names>H</given-names></name><name><surname>Meddings</surname><given-names>L</given-names></name><name><surname>Diederichs</surname><given-names>B</given-names></name><name><surname>Dmytrash</surname><given-names>A</given-names></name><name><surname>Backer</surname><given-names>J</given-names></name><etal></etal></person-group>
<article-title>Secreted bioactive factors from <italic>Bifidobacterium infantis</italic> enhance epithelial cell barrier function</article-title>. <source/>Am J Physiol Gastrointest Liver Physiol (<year>2008</year>) <volume>295</volume>(<issue>5</issue>):<fpage>G1025</fpage>–<lpage>34</lpage>.<pub-id pub-id-type="doi">10.1152/ajpgi.90227.2008</pub-id><pub-id pub-id-type="pmid">18787064</pub-id></mixed-citation>
</ref>
<ref id="B81">
<label>81</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahrne</surname><given-names>S</given-names></name><name><surname>Hagslatt</surname><given-names>ML</given-names></name></person-group>. <article-title>Effect of lactobacilli on paracellular permeability in the gut</article-title>. <source/>Nutrients (<year>2011</year>) <volume>3</volume>(<issue>1</issue>):<fpage>104</fpage>–<lpage>17</lpage>.<pub-id pub-id-type="doi">10.3390/nu3010104</pub-id><pub-id pub-id-type="pmid">22254077</pub-id></mixed-citation>
</ref>
<ref id="B82">
<label>82</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suzuki</surname><given-names>T</given-names></name></person-group>. <article-title>Regulation of intestinal epithelial permeability by tight junctions</article-title>. <source/>Cell Mol Life Sci (<year>2013</year>) <volume>70</volume>(<issue>4</issue>):<fpage>631</fpage>–<lpage>59</lpage>.<pub-id pub-id-type="doi">10.1007/s00018-012-1070-x</pub-id><pub-id pub-id-type="pmid">22782113</pub-id></mixed-citation>
</ref>
<ref id="B83">
<label>83</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Santis</surname><given-names>S</given-names></name><name><surname>Cavalcanti</surname><given-names>E</given-names></name><name><surname>Mastronardi</surname><given-names>M</given-names></name><name><surname>Jirillo</surname><given-names>E</given-names></name><name><surname>Chieppa</surname><given-names>M</given-names></name></person-group>. <article-title>Nutritional keys for intestinal barrier modulation</article-title>. <source/>Front Immunol (<year>2015</year>) <volume>6</volume>:<fpage>612</fpage>.<pub-id pub-id-type="doi">10.3389/fimmu.2015.00612</pub-id><pub-id pub-id-type="pmid">26697008</pub-id></mixed-citation>
</ref>
<ref id="B84">
<label>84</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kong</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Musch</surname><given-names>MW</given-names></name><name><surname>Ning</surname><given-names>G</given-names></name><name><surname>Sun</surname><given-names>J</given-names></name><name><surname>Hart</surname><given-names>J</given-names></name><etal></etal></person-group>
<article-title>Novel role of the vitamin D receptor in maintaining the integrity of the intestinal mucosal barrier</article-title>. <source/>Am J Physiol Gastrointest Liver Physiol (<year>2008</year>) <volume>294</volume>(<issue>1</issue>):<fpage>G208</fpage>–<lpage>16</lpage>.<pub-id pub-id-type="doi">10.1152/ajpgi.00398.2007</pub-id><pub-id pub-id-type="pmid">17962355</pub-id></mixed-citation>
</ref>
<ref id="B85">
<label>85</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>YG</given-names></name><name><surname>Wu</surname><given-names>S</given-names></name><name><surname>Lu</surname><given-names>R</given-names></name><name><surname>Zhou</surname><given-names>D</given-names></name><name><surname>Zhou</surname><given-names>J</given-names></name><name><surname>Carmeliet</surname><given-names>G</given-names></name><etal></etal></person-group>
<article-title>Tight junction CLDN2 gene is a direct target of the vitamin D receptor</article-title>. <source/>Sci Rep (<year>2015</year>) <volume>5</volume>:<fpage>10642</fpage>.<pub-id pub-id-type="doi">10.1038/srep10642</pub-id><pub-id pub-id-type="pmid">26212084</pub-id></mixed-citation>
</ref>
<ref id="B86">
<label>86</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lam</surname><given-names>YY</given-names></name><name><surname>Ha</surname><given-names>CW</given-names></name><name><surname>Campbell</surname><given-names>CR</given-names></name><name><surname>Mitchell</surname><given-names>AJ</given-names></name><name><surname>Dinudom</surname><given-names>A</given-names></name><name><surname>Oscarsson</surname><given-names>J</given-names></name><etal></etal></person-group>
<article-title>Increased gut permeability and microbiota change associate with mesenteric fat inflammation and metabolic dysfunction in diet-induced obese mice</article-title>. <source/>PLoS One (<year>2012</year>) <volume>7</volume>(<issue>3</issue>):<fpage>e34233</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pone.0034233</pub-id><pub-id pub-id-type="pmid">22457829</pub-id></mixed-citation>
</ref>
<ref id="B87">
<label>87</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>C</given-names></name><name><surname>Wang</surname><given-names>P</given-names></name><name><surname>Su</surname><given-names>Q</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>F</given-names></name></person-group>. <article-title>Myosin light chain kinase mediates intestinal barrier disruption following burn injury</article-title>. <source/>PLoS One (<year>2012</year>) <volume>7</volume>(<issue>4</issue>):<fpage>e34946</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pone.0034946</pub-id><pub-id pub-id-type="pmid">22529961</pub-id></mixed-citation>
</ref>
<ref id="B88">
<label>88</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Earley</surname><given-names>ZM</given-names></name><name><surname>Akhtar</surname><given-names>S</given-names></name><name><surname>Green</surname><given-names>SJ</given-names></name><name><surname>Naqib</surname><given-names>A</given-names></name><name><surname>Khan</surname><given-names>O</given-names></name><name><surname>Cannon</surname><given-names>AR</given-names></name><etal></etal></person-group>
<article-title>Burn injury alters the intestinal microbiome and increases gut permeability and bacterial translocation</article-title>. <source/>PLoS One (<year>2015</year>) <volume>10</volume>(<issue>7</issue>):<fpage>e0129996</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pone.0129996</pub-id><pub-id pub-id-type="pmid">26154283</pub-id></mixed-citation>
</ref>
<ref id="B89">
<label>89</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turner</surname><given-names>JR</given-names></name></person-group>. <article-title>Molecular basis of epithelial barrier regulation: from basic mechanisms to clinical application</article-title>. <source/>Am J Pathol (<year>2006</year>) <volume>169</volume>(<issue>6</issue>):<fpage>1901</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="doi">10.2353/ajpath.2006.060681</pub-id><pub-id pub-id-type="pmid">17148655</pub-id></mixed-citation>
</ref>
<ref id="B90">
<label>90</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turner</surname><given-names>JR</given-names></name></person-group>. <article-title>Intestinal mucosal barrier function in health and disease</article-title>. <source/>Nat Rev Immunol (<year>2009</year>) <volume>9</volume>(<issue>11</issue>):<fpage>799</fpage>–<lpage>809</lpage>.<pub-id pub-id-type="doi">10.1038/nri2653</pub-id><pub-id pub-id-type="pmid">19855405</pub-id></mixed-citation>
</ref>
<ref id="B91">
<label>91</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cunningham</surname><given-names>KE</given-names></name><name><surname>Turner</surname><given-names>JR</given-names></name></person-group>. <article-title>Myosin light chain kinase: pulling the strings of epithelial tight junction function</article-title>. <source/>Ann N Y Acad Sci (<year>2012</year>) <volume>1258</volume>:<fpage>34</fpage>–<lpage>42</lpage>.<pub-id pub-id-type="doi">10.1111/j.1749-6632.2012.06526.x</pub-id><pub-id pub-id-type="pmid">22731713</pub-id></mixed-citation>
</ref>
<ref id="B92">
<label>92</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuethe</surname><given-names>JW</given-names></name><name><surname>Armocida</surname><given-names>SM</given-names></name><name><surname>Midura</surname><given-names>EF</given-names></name><name><surname>Rice</surname><given-names>TC</given-names></name><name><surname>Hildeman</surname><given-names>DA</given-names></name><name><surname>Healy</surname><given-names>DP</given-names></name><etal></etal></person-group>
<article-title>Fecal microbiota transplant restores mucosal integrity in a murine model of burn injury</article-title>. <source/>Shock (<year>2016</year>) <volume>45</volume>(<issue>6</issue>):<fpage>647</fpage>–<lpage>52</lpage>.<pub-id pub-id-type="doi">10.1097/SHK.0000000000000551</pub-id><pub-id pub-id-type="pmid">26682948</pub-id></mixed-citation>
</ref>
<ref id="B93">
<label>93</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>P</given-names></name><name><surname>Starkel</surname><given-names>P</given-names></name><name><surname>Turner</surname><given-names>JR</given-names></name><name><surname>Ho</surname><given-names>SB</given-names></name><name><surname>Schnabl</surname><given-names>B</given-names></name></person-group>. <article-title>Dysbiosis-induced intestinal inflammation activates tumor necrosis factor receptor I and mediates alcoholic liver disease in mice</article-title>. <source/>Hepatology (<year>2015</year>) <volume>61</volume>(<issue>3</issue>):<fpage>883</fpage>–<lpage>94</lpage>.<pub-id pub-id-type="doi">10.1002/hep.27489</pub-id><pub-id pub-id-type="pmid">25251280</pub-id></mixed-citation>
</ref>
<ref id="B94">
<label>94</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>P</given-names></name><name><surname>Torralba</surname><given-names>M</given-names></name><name><surname>Tan</surname><given-names>J</given-names></name><name><surname>Embree</surname><given-names>M</given-names></name><name><surname>Zengler</surname><given-names>K</given-names></name><name><surname>Starkel</surname><given-names>P</given-names></name><etal></etal></person-group>
<article-title>Supplementation of saturated long-chain fatty acids maintains intestinal eubiosis and reduces ethanol-induced liver injury in mice</article-title>. <source/>Gastroenterology (<year>2015</year>) <volume>148</volume>(<issue>1</issue>):<fpage>203</fpage>–<lpage>14 e16</lpage>.<pub-id pub-id-type="doi">10.1053/j.gastro.2014.09.014</pub-id><pub-id pub-id-type="pmid">25239591</pub-id></mixed-citation>
</ref>
<ref id="B95">
<label>95</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adachi</surname><given-names>Y</given-names></name><name><surname>Moore</surname><given-names>LE</given-names></name><name><surname>Bradford</surname><given-names>BU</given-names></name><name><surname>Gao</surname><given-names>W</given-names></name><name><surname>Thurman</surname><given-names>RG</given-names></name></person-group>. <article-title>Antibiotics prevent liver injury in rats following long-term exposure to ethanol</article-title>. <source/>Gastroenterology (<year>1995</year>) <volume>108</volume>(<issue>1</issue>):<fpage>218</fpage>–<lpage>24</lpage>.<pub-id pub-id-type="doi">10.1016/0016-5085(95)90027-6</pub-id><pub-id pub-id-type="pmid">7806045</pub-id></mixed-citation>
</ref>
<ref id="B96">
<label>96</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Casafont Morencos</surname><given-names>F</given-names></name><name><surname>de las Heras Castano</surname><given-names>G</given-names></name><name><surname>Martin Ramos</surname><given-names>L</given-names></name><name><surname>Lopez Arias</surname><given-names>MJ</given-names></name><name><surname>Ledesma</surname><given-names>F</given-names></name><name><surname>Pons Romero</surname><given-names>F</given-names></name></person-group>. <article-title>Small bowel bacterial overgrowth in patients with alcoholic cirrhosis</article-title>. <source/>Dig Dis Sci (<year>1996</year>) <volume>41</volume>(<issue>3</issue>):<fpage>552</fpage>–<lpage>6</lpage>.<pub-id pub-id-type="doi">10.1007/BF02282340</pub-id><pub-id pub-id-type="pmid">8617135</pub-id></mixed-citation>
</ref>
<ref id="B97">
<label>97</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mutlu</surname><given-names>EA</given-names></name><name><surname>Gillevet</surname><given-names>PM</given-names></name><name><surname>Rangwala</surname><given-names>H</given-names></name><name><surname>Sikaroodi</surname><given-names>M</given-names></name><name><surname>Naqvi</surname><given-names>A</given-names></name><name><surname>Engen</surname><given-names>PA</given-names></name><etal></etal></person-group>
<article-title>Colonic microbiome is altered in alcoholism</article-title>. <source/>Am J Physiol Gastrointest Liver Physiol (<year>2012</year>) <volume>302</volume>(<issue>9</issue>):<fpage>G966</fpage>–<lpage>78</lpage>.<pub-id pub-id-type="doi">10.1152/ajpgi.00380.2011</pub-id><pub-id pub-id-type="pmid">22241860</pub-id></mixed-citation>
</ref>
<ref id="B98">
<label>98</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Forsyth</surname><given-names>CB</given-names></name><name><surname>Farhadi</surname><given-names>A</given-names></name><name><surname>Jakate</surname><given-names>SM</given-names></name><name><surname>Tang</surname><given-names>Y</given-names></name><name><surname>Shaikh</surname><given-names>M</given-names></name><name><surname>Keshavarzian</surname><given-names>A</given-names></name></person-group>. <article-title>Lactobacillus GG treatment ameliorates alcohol-induced intestinal oxidative stress, gut leakiness, and liver injury in a rat model of alcoholic steatohepatitis</article-title>. <source/>Alcohol (<year>2009</year>) <volume>43</volume>(<issue>2</issue>):<fpage>163</fpage>–<lpage>72</lpage>.<pub-id pub-id-type="doi">10.1016/j.alcohol.2008.12.009</pub-id><pub-id pub-id-type="pmid">19251117</pub-id></mixed-citation>
</ref>
<ref id="B99">
<label>99</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Kirpich</surname><given-names>I</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Ma</surname><given-names>Z</given-names></name><name><surname>Barve</surname><given-names>S</given-names></name><name><surname>McClain</surname><given-names>CJ</given-names></name><etal></etal></person-group>
<article-title><italic>Lactobacillus rhamnosus</italic> GG treatment potentiates intestinal hypoxia-inducible factor, promotes intestinal integrity and ameliorates alcohol-induced liver injury</article-title>. <source/>Am J Pathol (<year>2011</year>) <volume>179</volume>(<issue>6</issue>):<fpage>2866</fpage>–<lpage>75</lpage>.<pub-id pub-id-type="doi">10.1016/j.ajpath.2011.08.039</pub-id><pub-id pub-id-type="pmid">22093263</pub-id></mixed-citation>
</ref>
<ref id="B100">
<label>100</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parlesak</surname><given-names>A</given-names></name><name><surname>Schafer</surname><given-names>C</given-names></name><name><surname>Schutz</surname><given-names>T</given-names></name><name><surname>Bode</surname><given-names>JC</given-names></name><name><surname>Bode</surname><given-names>C</given-names></name></person-group>. <article-title>Increased intestinal permeability to macromolecules and endotoxemia in patients with chronic alcohol abuse in different stages of alcohol-induced liver disease</article-title>. <source/>J Hepatol (<year>2000</year>) <volume>32</volume>(<issue>5</issue>):<fpage>742</fpage>–<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1016/S0168-8278(00)80242-1</pub-id><pub-id pub-id-type="pmid">10845660</pub-id></mixed-citation>
</ref>
<ref id="B101">
<label>101</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uesugi</surname><given-names>T</given-names></name><name><surname>Froh</surname><given-names>M</given-names></name><name><surname>Arteel</surname><given-names>GE</given-names></name><name><surname>Bradford</surname><given-names>BU</given-names></name><name><surname>Thurman</surname><given-names>RG</given-names></name></person-group>. <article-title>Toll-like receptor 4 is involved in the mechanism of early alcohol-induced liver injury in mice</article-title>. <source/>Hepatology (<year>2001</year>) <volume>34</volume>(<issue>1</issue>):<fpage>101</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1053/jhep.2001.25350</pub-id><pub-id pub-id-type="pmid">11431739</pub-id></mixed-citation>
</ref>
<ref id="B102">
<label>102</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elshaghabee</surname><given-names>FM</given-names></name><name><surname>Bockelmann</surname><given-names>W</given-names></name><name><surname>Meske</surname><given-names>D</given-names></name><name><surname>de Vrese</surname><given-names>M</given-names></name><name><surname>Walte</surname><given-names>HG</given-names></name><name><surname>Schrezenmeir</surname><given-names>J</given-names></name><etal></etal></person-group>
<article-title>Ethanol production by selected intestinal microorganisms and lactic acid bacteria growing under different nutritional conditions</article-title>. <source/>Front Microbiol (<year>2016</year>) <volume>7</volume>:<fpage>47</fpage>.<pub-id pub-id-type="doi">10.3389/fmicb.2016.00047</pub-id><pub-id pub-id-type="pmid">26858714</pub-id></mixed-citation>
</ref>
<ref id="B103">
<label>103</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tyler</surname><given-names>AD</given-names></name><name><surname>Knox</surname><given-names>N</given-names></name><name><surname>Kabakchiev</surname><given-names>B</given-names></name><name><surname>Milgrom</surname><given-names>R</given-names></name><name><surname>Kirsch</surname><given-names>R</given-names></name><name><surname>Cohen</surname><given-names>Z</given-names></name><etal></etal></person-group>
<article-title>Characterization of the gut-associated microbiome in inflammatory pouch complications following ileal pouch-anal anastomosis</article-title>. <source/>PLoS One (<year>2013</year>) <volume>8</volume>(<issue>9</issue>):<fpage>e66934</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pone.0066934</pub-id><pub-id pub-id-type="pmid">24086242</pub-id></mixed-citation>
</ref>
<ref id="B104">
<label>104</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>QH</given-names></name><name><surname>Yang</surname><given-names>Q</given-names></name></person-group>. <article-title>Diversity of tight junctions (TJs) between gastrointestinal epithelial cells and their function in maintaining the mucosal barrier</article-title>. <source/>Cell Biol Int (<year>2009</year>) <volume>33</volume>(<issue>1</issue>):<fpage>78</fpage>–<lpage>82</lpage>.<pub-id pub-id-type="doi">10.1016/j.cellbi.2008.09.007</pub-id><pub-id pub-id-type="pmid">18938254</pub-id></mixed-citation>
</ref>
<ref id="B105">
<label>105</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Amieva</surname><given-names>MR</given-names></name><name><surname>Vogelmann</surname><given-names>R</given-names></name><name><surname>Covacci</surname><given-names>A</given-names></name><name><surname>Tompkins</surname><given-names>LS</given-names></name><name><surname>Nelson</surname><given-names>WJ</given-names></name><name><surname>Falkow</surname><given-names>S</given-names></name></person-group>. <article-title>Disruption of the epithelial apical-junctional complex by <italic>Helicobacter pylori</italic> CagA</article-title>. <source/>Science (<year>2003</year>) <volume>300</volume>(<issue>5624</issue>):<fpage>1430</fpage>–<lpage>4</lpage>.<pub-id pub-id-type="doi">10.1126/science.1081919</pub-id><pub-id pub-id-type="pmid">12775840</pub-id></mixed-citation>
</ref>
<ref id="B106">
<label>106</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fedwick</surname><given-names>JP</given-names></name><name><surname>Lapointe</surname><given-names>TK</given-names></name><name><surname>Meddings</surname><given-names>JB</given-names></name><name><surname>Sherman</surname><given-names>PM</given-names></name><name><surname>Buret</surname><given-names>AG</given-names></name></person-group>. <article-title><italic>Helicobacter pylori</italic> activates myosin light-chain kinase to disrupt claudin-4 and claudin-5 and increase epithelial permeability</article-title>. <source/>Infect Immun (<year>2005</year>) <volume>73</volume>(<issue>12</issue>):<fpage>7844</fpage>–<lpage>52</lpage>.<pub-id pub-id-type="doi">10.1128/IAI.73.12.7844-7852.2005</pub-id><pub-id pub-id-type="pmid">16299274</pub-id></mixed-citation>
</ref>
<ref id="B107">
<label>107</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tetz</surname><given-names>G</given-names></name><name><surname>Tetz</surname><given-names>V</given-names></name></person-group>. <article-title>Bacteriophage infections of microbiota can lead to leaky gut in an experimental rodent model</article-title>. <source/>Gut Pathog (<year>2016</year>) <volume>8</volume>:<fpage>33</fpage>.<pub-id pub-id-type="doi">10.1186/s13099-016-0109-1</pub-id><pub-id pub-id-type="pmid">27340433</pub-id></mixed-citation>
</ref>
<ref id="B108">
<label>108</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kawasaki</surname><given-names>E</given-names></name></person-group>
<article-title>Type 1 diabetes and autoimmunity</article-title>. <source/>Clin Pediatr Endocrinol (<year>2014</year>) <volume>23</volume>(<issue>4</issue>):<fpage>99</fpage>–<lpage>105</lpage>.<pub-id pub-id-type="doi">10.1297/cpe.23.99</pub-id><pub-id pub-id-type="pmid">25374439</pub-id></mixed-citation>
</ref>
<ref id="B109">
<label>109</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Odenwald</surname><given-names>MA</given-names></name><name><surname>Turner</surname><given-names>JR</given-names></name></person-group>. <article-title>Intestinal permeability defects: is it time to treat?</article-title>
<source/>Clin Gastroenterol Hepatol (<year>2013</year>) <volume>11</volume>(<issue>9</issue>):<fpage>1075</fpage>–<lpage>83</lpage>.<pub-id pub-id-type="doi">10.1016/j.cgh.2013.07.001</pub-id><pub-id pub-id-type="pmid">23851019</pub-id></mixed-citation>
</ref>
<ref id="B110">
<label>110</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Damci</surname><given-names>T</given-names></name><name><surname>Nuhoglu</surname><given-names>I</given-names></name><name><surname>Devranoglu</surname><given-names>G</given-names></name><name><surname>Osar</surname><given-names>Z</given-names></name><name><surname>Demir</surname><given-names>M</given-names></name><name><surname>Ilkova</surname><given-names>H</given-names></name></person-group>. <article-title>Increased intestinal permeability as a cause of fluctuating postprandial blood glucose levels in type 1 diabetic patients</article-title>. <source/>Eur J Clin Invest (<year>2003</year>) <volume>33</volume>(<issue>5</issue>):<fpage>397</fpage>–<lpage>401</lpage>.<pub-id pub-id-type="doi">10.1046/j.1365-2362.2003.01161.x</pub-id><pub-id pub-id-type="pmid">12713453</pub-id></mixed-citation>
</ref>
<ref id="B111">
<label>111</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meddings</surname><given-names>JB</given-names></name><name><surname>Jarand</surname><given-names>J</given-names></name><name><surname>Urbanski</surname><given-names>SJ</given-names></name><name><surname>Hardin</surname><given-names>J</given-names></name><name><surname>Gall</surname><given-names>DG</given-names></name></person-group>. <article-title>Increased gastrointestinal permeability is an early lesion in the spontaneously diabetic BB rat</article-title>. <source/>Am J Physiol (<year>1999</year>) <volume>276</volume>(<issue>4 Pt 1</issue>):<fpage>G951</fpage>–<lpage>7</lpage>.<pub-id pub-id-type="pmid">10198339</pub-id></mixed-citation>
</ref>
<ref id="B112">
<label>112</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Secondulfo</surname><given-names>M</given-names></name><name><surname>Iafusco</surname><given-names>D</given-names></name><name><surname>Carratu</surname><given-names>R</given-names></name><name><surname>deMagistris</surname><given-names>L</given-names></name><name><surname>Sapone</surname><given-names>A</given-names></name><name><surname>Generoso</surname><given-names>M</given-names></name><etal></etal></person-group>
<article-title>Ultrastructural mucosal alterations and increased intestinal permeability in non-celiac, type I diabetic patients</article-title>. <source/>Dig Liver Dis (<year>2004</year>) <volume>36</volume>(<issue>1</issue>):<fpage>35</fpage>–<lpage>45</lpage>.<pub-id pub-id-type="doi">10.1016/j.dld.2003.09.016</pub-id><pub-id pub-id-type="pmid">14971814</pub-id></mixed-citation>
</ref>
<ref id="B113">
<label>113</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>El Asmar</surname><given-names>R</given-names></name><name><surname>Panigrahi</surname><given-names>P</given-names></name><name><surname>Bamford</surname><given-names>P</given-names></name><name><surname>Berti</surname><given-names>I</given-names></name><name><surname>Not</surname><given-names>T</given-names></name><name><surname>Coppa</surname><given-names>GV</given-names></name><etal></etal></person-group>
<article-title>Host-dependent zonulin secretion causes the impairment of the small intestine barrier function after bacterial exposure</article-title>. <source/>Gastroenterology (<year>2002</year>) <volume>123</volume>(<issue>5</issue>):<fpage>1607</fpage>–<lpage>15</lpage>.<pub-id pub-id-type="doi">10.1053/gast.2002.36578</pub-id><pub-id pub-id-type="pmid">12404235</pub-id></mixed-citation>
</ref>
<ref id="B114">
<label>114</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watts</surname><given-names>T</given-names></name><name><surname>Berti</surname><given-names>I</given-names></name><name><surname>Sapone</surname><given-names>A</given-names></name><name><surname>Gerarduzzi</surname><given-names>T</given-names></name><name><surname>Not</surname><given-names>T</given-names></name><name><surname>Zielke</surname><given-names>R</given-names></name><etal></etal></person-group>
<article-title>Role of the intestinal tight junction modulator zonulin in the pathogenesis of type I diabetes in BB diabetic-prone rats</article-title>. <source/>Proc Natl Acad Sci U S A (<year>2005</year>) <volume>102</volume>(<issue>8</issue>):<fpage>2916</fpage>–<lpage>21</lpage>.<pub-id pub-id-type="doi">10.1073/pnas.0500178102</pub-id><pub-id pub-id-type="pmid">15710870</pub-id></mixed-citation>
</ref>
<ref id="B115">
<label>115</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Costa</surname><given-names>FR</given-names></name><name><surname>Francozo</surname><given-names>MC</given-names></name><name><surname>de Oliveira</surname><given-names>GG</given-names></name><name><surname>Ignacio</surname><given-names>A</given-names></name><name><surname>Castoldi</surname><given-names>A</given-names></name><name><surname>Zamboni</surname><given-names>DS</given-names></name><etal></etal></person-group>
<article-title>Gut microbiota translocation to the pancreatic lymph nodes triggers NOD2 activation and contributes to T1D onset</article-title>. <source/>J Exp Med (<year>2016</year>) <volume>213</volume>(<issue>7</issue>):<fpage>1223</fpage>–<lpage>39</lpage>.<pub-id pub-id-type="doi">10.1084/jem.20150744</pub-id><pub-id pub-id-type="pmid">27325889</pub-id></mixed-citation>
</ref>
<ref id="B116">
<label>116</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsokos</surname><given-names>GC</given-names></name></person-group>
<article-title>Systemic lupus erythematosus</article-title>. <source/>N Engl J Med (<year>2011</year>) <volume>365</volume>(<issue>22</issue>):<fpage>2110</fpage>–<lpage>21</lpage>.<pub-id pub-id-type="doi">10.1056/NEJMra1100359</pub-id><pub-id pub-id-type="pmid">22129255</pub-id></mixed-citation>
</ref>
<ref id="B117">
<label>117</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mu</surname><given-names>Q</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Luo</surname><given-names>XM</given-names></name></person-group>. <article-title>SLE: another autoimmune disorder influenced by microbes and diet?</article-title>
<source/>Front Immunol (<year>2015</year>) <volume>6</volume>:<fpage>608</fpage>.<pub-id pub-id-type="doi">10.3389/fimmu.2015.00608</pub-id><pub-id pub-id-type="pmid">26648937</pub-id></mixed-citation>
</ref>
<ref id="B118">
<label>118</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nockher</surname><given-names>WA</given-names></name><name><surname>Wigand</surname><given-names>R</given-names></name><name><surname>Schoeppe</surname><given-names>W</given-names></name><name><surname>Scherberich</surname><given-names>JE</given-names></name></person-group>. <article-title>Elevated levels of soluble CD14 in serum of patients with systemic lupus erythematosus</article-title>. <source/>Clin Exp Immunol (<year>1994</year>) <volume>96</volume>(<issue>1</issue>):<fpage>15</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1111/j.1365-2249.1994.tb06222.x</pub-id><pub-id pub-id-type="pmid">7512005</pub-id></mixed-citation>
</ref>
<ref id="B119">
<label>119</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>TP</given-names></name><name><surname>Huang</surname><given-names>JC</given-names></name><name><surname>Liu</surname><given-names>CJ</given-names></name><name><surname>Chen</surname><given-names>HJ</given-names></name><name><surname>Chen</surname><given-names>YH</given-names></name><name><surname>Tsai</surname><given-names>YT</given-names></name><etal></etal></person-group>
<article-title>Interactions of surface-expressed TLR-4 and endosomal TLR-9 accelerate lupus progression in anti-dsDNA antibody transgenic mice</article-title>. <source/>Exp Biol Med (Maywood) (<year>2014</year>) <volume>239</volume>(<issue>6</issue>):<fpage>715</fpage>–<lpage>23</lpage>.<pub-id pub-id-type="doi">10.1177/1535370214525299</pub-id><pub-id pub-id-type="pmid">24719374</pub-id></mixed-citation>
</ref>
<ref id="B120">
<label>120</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>TP</given-names></name><name><surname>Tang</surname><given-names>SJ</given-names></name><name><surname>Wu</surname><given-names>MF</given-names></name><name><surname>Song</surname><given-names>YC</given-names></name><name><surname>Yu</surname><given-names>CL</given-names></name><name><surname>Sun</surname><given-names>KH</given-names></name></person-group>. <article-title>Transgenic overexpression of anti-double-stranded DNA autoantibody and activation of Toll-like receptor 4 in mice induce severe systemic lupus erythematosus syndromes</article-title>. <source/>J Autoimmun (<year>2010</year>) <volume>35</volume>(<issue>4</issue>):<fpage>358</fpage>–<lpage>67</lpage>.<pub-id pub-id-type="doi">10.1016/j.jaut.2010.07.007</pub-id><pub-id pub-id-type="pmid">20833510</pub-id></mixed-citation>
</ref>
<ref id="B121">
<label>121</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>B</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Dai</surname><given-names>J</given-names></name><name><surname>Medzhitov</surname><given-names>R</given-names></name><name><surname>Freudenberg</surname><given-names>MA</given-names></name><name><surname>Zhang</surname><given-names>PL</given-names></name><etal></etal></person-group>
<article-title>TLR4 up-regulation at protein or gene level is pathogenic for lupus-like autoimmune disease</article-title>. <source/>J Immunol (<year>2006</year>) <volume>177</volume>(<issue>10</issue>):<fpage>6880</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.177.10.6880</pub-id><pub-id pub-id-type="pmid">17082602</pub-id></mixed-citation>
</ref>
<ref id="B122">
<label>122</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levine</surname><given-names>JS</given-names></name><name><surname>Subang</surname><given-names>R</given-names></name><name><surname>Nasr</surname><given-names>SH</given-names></name><name><surname>Fournier</surname><given-names>S</given-names></name><name><surname>Lajoie</surname><given-names>G</given-names></name><name><surname>Wither</surname><given-names>J</given-names></name><etal></etal></person-group>
<article-title>Immunization with an apoptotic cell-binding protein recapitulates the nephritis and sequential autoantibody emergence of systemic lupus erythematosus</article-title>. <source/>J Immunol (<year>2006</year>) <volume>177</volume>(<issue>9</issue>):<fpage>6504</fpage>–<lpage>16</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.177.9.6504</pub-id><pub-id pub-id-type="pmid">17056583</pub-id></mixed-citation>
</ref>
<ref id="B123">
<label>123</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levine</surname><given-names>JS</given-names></name><name><surname>Subang</surname><given-names>R</given-names></name><name><surname>Setty</surname><given-names>S</given-names></name><name><surname>Cabrera</surname><given-names>J</given-names></name><name><surname>Laplante</surname><given-names>P</given-names></name><name><surname>Fritzler</surname><given-names>MJ</given-names></name><etal></etal></person-group>
<article-title>Phospholipid-binding proteins differ in their capacity to induce autoantibodies and murine systemic lupus erythematosus</article-title>. <source/>Lupus (<year>2014</year>) <volume>23</volume>(<issue>8</issue>):<fpage>752</fpage>–<lpage>68</lpage>.<pub-id pub-id-type="doi">10.1177/0961203314525676</pub-id><pub-id pub-id-type="pmid">24695867</pub-id></mixed-citation>
</ref>
<ref id="B124">
<label>124</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tolomeo</surname><given-names>T</given-names></name><name><surname>Rico De Souza</surname><given-names>A</given-names></name><name><surname>Roter</surname><given-names>E</given-names></name><name><surname>Dieude</surname><given-names>M</given-names></name><name><surname>Amireault</surname><given-names>P</given-names></name><name><surname>Subang</surname><given-names>R</given-names></name><etal></etal></person-group>
<article-title>T cells demonstrate a Th1-biased response to native beta2-glycoprotein I in a murine model of anti-phospholipid antibody induction</article-title>. <source/>Autoimmunity (<year>2009</year>) <volume>42</volume>(<issue>4</issue>):<fpage>292</fpage>–<lpage>5</lpage>.<pub-id pub-id-type="doi">10.1080/08916930902828254</pub-id><pub-id pub-id-type="pmid">19811280</pub-id></mixed-citation>
</ref>
<ref id="B125">
<label>125</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lartigue</surname><given-names>A</given-names></name><name><surname>Colliou</surname><given-names>N</given-names></name><name><surname>Calbo</surname><given-names>S</given-names></name><name><surname>Francois</surname><given-names>A</given-names></name><name><surname>Jacquot</surname><given-names>S</given-names></name><name><surname>Arnoult</surname><given-names>C</given-names></name><etal></etal></person-group>
<article-title>Critical role of TLR2 and TLR4 in autoantibody production and glomerulonephritis in lpr mutation-induced mouse lupus</article-title>. <source/>J Immunol (<year>2009</year>) <volume>183</volume>(<issue>10</issue>):<fpage>6207</fpage>–<lpage>16</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.0803219</pub-id><pub-id pub-id-type="pmid">19841185</pub-id></mixed-citation>
</ref>
<ref id="B126">
<label>126</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Summers</surname><given-names>SA</given-names></name><name><surname>Hoi</surname><given-names>A</given-names></name><name><surname>Steinmetz</surname><given-names>OM</given-names></name><name><surname>O’Sullivan</surname><given-names>KM</given-names></name><name><surname>Ooi</surname><given-names>JD</given-names></name><name><surname>Odobasic</surname><given-names>D</given-names></name><etal></etal></person-group>
<article-title>TLR9 and TLR4 are required for the development of autoimmunity and lupus nephritis in pristane nephropathy</article-title>. <source/>J Autoimmun (<year>2010</year>) <volume>35</volume>(<issue>4</issue>):<fpage>291</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1016/j.jaut.2010.05.004</pub-id><pub-id pub-id-type="pmid">20810248</pub-id></mixed-citation>
</ref>
<ref id="B127">
<label>127</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Liao</surname><given-names>J</given-names></name><name><surname>Zhao</surname><given-names>M</given-names></name><name><surname>Wu</surname><given-names>H</given-names></name><name><surname>Yung</surname><given-names>S</given-names></name><name><surname>Chan</surname><given-names>TM</given-names></name><etal></etal></person-group>
<article-title>Increased expression of TLR2 in CD4(+) T cells from SLE patients enhances immune reactivity and promotes IL-17 expression through histone modifications</article-title>. <source/>Eur J Immunol (<year>2015</year>) <volume>45</volume>(<issue>9</issue>):<fpage>2683</fpage>–<lpage>93</lpage>.<pub-id pub-id-type="doi">10.1002/eji.201445219</pub-id><pub-id pub-id-type="pmid">26079624</pub-id></mixed-citation>
</ref>
<ref id="B128">
<label>128</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leiss</surname><given-names>H</given-names></name><name><surname>Niederreiter</surname><given-names>B</given-names></name><name><surname>Bandur</surname><given-names>T</given-names></name><name><surname>Schwarzecker</surname><given-names>B</given-names></name><name><surname>Bluml</surname><given-names>S</given-names></name><name><surname>Steiner</surname><given-names>G</given-names></name><etal></etal></person-group>
<article-title>Pristane-induced lupus as a model of human lupus arthritis: evolvement of autoantibodies, internal organ and joint inflammation</article-title>. <source/>Lupus (<year>2013</year>) <volume>22</volume>(<issue>8</issue>):<fpage>778</fpage>–<lpage>92</lpage>.<pub-id pub-id-type="doi">10.1177/0961203313492869</pub-id><pub-id pub-id-type="pmid">23817510</pub-id></mixed-citation>
</ref>
<ref id="B129">
<label>129</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pawar</surname><given-names>RD</given-names></name><name><surname>Castrezana-Lopez</surname><given-names>L</given-names></name><name><surname>Allam</surname><given-names>R</given-names></name><name><surname>Kulkarni</surname><given-names>OP</given-names></name><name><surname>Segerer</surname><given-names>S</given-names></name><name><surname>Radomska</surname><given-names>E</given-names></name><etal></etal></person-group>
<article-title>Bacterial lipopeptide triggers massive albuminuria in murine lupus nephritis by activating toll-like receptor 2 at the glomerular filtration barrier</article-title>. <source/>Immunology (<year>2009</year>) <volume>128</volume>(<issue>1 Suppl</issue>):<fpage>e206</fpage>–<lpage>21</lpage>.<pub-id pub-id-type="doi">10.1111/j.1365-2567.2008.02948.x</pub-id><pub-id pub-id-type="pmid">19175801</pub-id></mixed-citation>
</ref>
<ref id="B130">
<label>130</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Urbonaviciute</surname><given-names>V</given-names></name><name><surname>Starke</surname><given-names>C</given-names></name><name><surname>Pirschel</surname><given-names>W</given-names></name><name><surname>Pohle</surname><given-names>S</given-names></name><name><surname>Frey</surname><given-names>S</given-names></name><name><surname>Daniel</surname><given-names>C</given-names></name><etal></etal></person-group>
<article-title>Toll-like receptor 2 is required for autoantibody production and development of renal disease in pristane-induced lupus</article-title>. <source/>Arthritis Rheum (<year>2013</year>) <volume>65</volume>(<issue>6</issue>):<fpage>1612</fpage>–<lpage>23</lpage>.<pub-id pub-id-type="doi">10.1002/art.37914</pub-id><pub-id pub-id-type="pmid">23450347</pub-id></mixed-citation>
</ref>
<ref id="B131">
<label>131</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gallo</surname><given-names>PM</given-names></name><name><surname>Rapsinski</surname><given-names>GJ</given-names></name><name><surname>Wilson</surname><given-names>RP</given-names></name><name><surname>Oppong</surname><given-names>GO</given-names></name><name><surname>Sriram</surname><given-names>U</given-names></name><name><surname>Goulian</surname><given-names>M</given-names></name><etal></etal></person-group>
<article-title>Amyloid-DNA composites of bacterial biofilms stimulate autoimmunity</article-title>. <source/>Immunity (<year>2015</year>) <volume>42</volume>(<issue>6</issue>):<fpage>1171</fpage>–<lpage>84</lpage>.<pub-id pub-id-type="doi">10.1016/j.immuni.2015.06.002</pub-id><pub-id pub-id-type="pmid">26084027</pub-id></mixed-citation>
</ref>
<ref id="B132">
<label>132</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>YW</given-names></name><name><surname>Tang</surname><given-names>W</given-names></name><name><surname>Zuo</surname><given-names>JP</given-names></name></person-group>
<article-title>Toll-like receptors: potential targets for lupus treatment</article-title>. <source/>Acta Pharmacol Sin (<year>2015</year>) <volume>36</volume>(<issue>12</issue>):<fpage>1395</fpage>–<lpage>407</lpage>.<pub-id pub-id-type="doi">10.1038/aps.2015.91</pub-id><pub-id pub-id-type="pmid">26592511</pub-id></mixed-citation>
</ref>
<ref id="B133">
<label>133</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teichmann</surname><given-names>LL</given-names></name><name><surname>Schenten</surname><given-names>D</given-names></name><name><surname>Medzhitov</surname><given-names>R</given-names></name><name><surname>Kashgarian</surname><given-names>M</given-names></name><name><surname>Shlomchik</surname><given-names>MJ</given-names></name></person-group>. <article-title>Signals via the adaptor MyD88 in B cells and DCs make distinct and synergistic contributions to immune activation and tissue damage in lupus</article-title>. <source/>Immunity (<year>2013</year>) <volume>38</volume>(<issue>3</issue>):<fpage>528</fpage>–<lpage>40</lpage>.<pub-id pub-id-type="doi">10.1016/j.immuni.2012.11.017</pub-id><pub-id pub-id-type="pmid">23499488</pub-id></mixed-citation>
</ref>
<ref id="B134">
<label>134</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nickerson</surname><given-names>KM</given-names></name><name><surname>Christensen</surname><given-names>SR</given-names></name><name><surname>Shupe</surname><given-names>J</given-names></name><name><surname>Kashgarian</surname><given-names>M</given-names></name><name><surname>Kim</surname><given-names>D</given-names></name><name><surname>Elkon</surname><given-names>K</given-names></name><etal></etal></person-group>
<article-title>TLR9 regulates TLR7- and MyD88-dependent autoantibody production and disease in a murine model of lupus</article-title>. <source/>J Immunol (<year>2010</year>) <volume>184</volume>(<issue>4</issue>):<fpage>1840</fpage>–<lpage>8</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.0902592</pub-id><pub-id pub-id-type="pmid">20089701</pub-id></mixed-citation>
</ref>
<ref id="B135">
<label>135</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karki</surname><given-names>R</given-names></name><name><surname>Man</surname><given-names>SM</given-names></name><name><surname>Kanneganti</surname><given-names>TD</given-names></name></person-group>. <article-title>Inflammasomes and cancer</article-title>. <source/>Cancer Immunol Res (<year>2017</year>) <volume>5</volume>(<issue>2</issue>):<fpage>94</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1158/2326-6066.CIR-16-0269</pub-id><pub-id pub-id-type="pmid">28093447</pub-id></mixed-citation>
</ref>
<ref id="B136">
<label>136</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karki</surname><given-names>R</given-names></name><name><surname>Man</surname><given-names>SM</given-names></name><name><surname>Malireddi</surname><given-names>RK</given-names></name><name><surname>Kesavardhana</surname><given-names>S</given-names></name><name><surname>Zhu</surname><given-names>Q</given-names></name><name><surname>Burton</surname><given-names>AR</given-names></name><etal></etal></person-group>
<article-title>NLRC3 is an inhibitory sensor of PI3K-mTOR pathways in cancer</article-title>. <source/>Nature (<year>2016</year>) <volume>540</volume>:<fpage>583</fpage>–<lpage>87</lpage>.<pub-id pub-id-type="doi">10.1038/nature20597</pub-id><pub-id pub-id-type="pmid">27951586</pub-id></mixed-citation>
</ref>
<ref id="B137">
<label>137</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sester</surname><given-names>DP</given-names></name><name><surname>Sagulenko</surname><given-names>V</given-names></name><name><surname>Thygesen</surname><given-names>SJ</given-names></name><name><surname>Cridland</surname><given-names>JA</given-names></name><name><surname>Loi</surname><given-names>YS</given-names></name><name><surname>Cridland</surname><given-names>SO</given-names></name><etal></etal></person-group>
<article-title>Deficient NLRP3 and AIM2 inflammasome function in autoimmune NZB mice</article-title>. <source/>J Immunol (<year>2015</year>) <volume>195</volume>(<issue>3</issue>):<fpage>1233</fpage>–<lpage>41</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.1402859</pub-id><pub-id pub-id-type="pmid">26116505</pub-id></mixed-citation>
</ref>
<ref id="B138">
<label>138</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lech</surname><given-names>M</given-names></name><name><surname>Lorenz</surname><given-names>G</given-names></name><name><surname>Kulkarni</surname><given-names>OP</given-names></name><name><surname>Grosser</surname><given-names>MO</given-names></name><name><surname>Stigrot</surname><given-names>N</given-names></name><name><surname>Darisipudi</surname><given-names>MN</given-names></name><etal></etal></person-group>
<article-title>NLRP3 and ASC suppress lupus-like autoimmunity by driving the immunosuppressive effects of TGF-beta receptor signalling</article-title>. <source/>Ann Rheum Dis (<year>2015</year>) <volume>74</volume>(<issue>12</issue>):<fpage>2224</fpage>–<lpage>35</lpage>.<pub-id pub-id-type="doi">10.1136/annrheumdis-2014-205496</pub-id><pub-id pub-id-type="pmid">25135254</pub-id></mixed-citation>
</ref>
<ref id="B139">
<label>139</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lamprecht</surname><given-names>M</given-names></name><name><surname>Bogner</surname><given-names>S</given-names></name><name><surname>Schippinger</surname><given-names>G</given-names></name><name><surname>Steinbauer</surname><given-names>K</given-names></name><name><surname>Fankhauser</surname><given-names>F</given-names></name><name><surname>Hallstroem</surname><given-names>S</given-names></name><etal></etal></person-group>
<article-title>Probiotic supplementation affects markers of intestinal barrier, oxidation, and inflammation in trained men; a randomized, double-blinded, placebo-controlled trial</article-title>. <source/>J Int Soc Sports Nutr (<year>2012</year>) <volume>9</volume>(<issue>1</issue>):<fpage>45</fpage><pub-id pub-id-type="doi">10.1186/1550-2783-9-45</pub-id><pub-id pub-id-type="pmid">22992437</pub-id></mixed-citation>
</ref>
<ref id="B140">
<label>140</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hsiao</surname><given-names>EY</given-names></name><name><surname>McBride</surname><given-names>SW</given-names></name><name><surname>Hsien</surname><given-names>S</given-names></name><name><surname>Sharon</surname><given-names>G</given-names></name><name><surname>Hyde</surname><given-names>ER</given-names></name><name><surname>McCue</surname><given-names>T</given-names></name><etal></etal></person-group>
<article-title>Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders</article-title>. <source/>Cell (<year>2013</year>) <volume>155</volume>(<issue>7</issue>):<fpage>1451</fpage>–<lpage>63</lpage>.<pub-id pub-id-type="doi">10.1016/j.cell.2013.11.024</pub-id><pub-id pub-id-type="pmid">24315484</pub-id></mixed-citation>
</ref>
<ref id="B141">
<label>141</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Round</surname><given-names>JL</given-names></name><name><surname>Mazmanian</surname><given-names>SK</given-names></name></person-group>. <article-title>Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota</article-title>. <source/>Proc Natl Acad Sci U S A (<year>2010</year>) <volume>107</volume>(<issue>27</issue>):<fpage>12204</fpage>–<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1073/pnas.0909122107</pub-id><pub-id pub-id-type="pmid">20566854</pub-id></mixed-citation>
</ref>
<ref id="B142">
<label>142</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Telesford</surname><given-names>KM</given-names></name><name><surname>Yan</surname><given-names>W</given-names></name><name><surname>Ochoa-Reparaz</surname><given-names>J</given-names></name><name><surname>Pant</surname><given-names>A</given-names></name><name><surname>Kircher</surname><given-names>C</given-names></name><name><surname>Christy</surname><given-names>MA</given-names></name><etal></etal></person-group>
<article-title>A commensal symbiotic factor derived from <italic>Bacteroides fragilis</italic> promotes human CD39(+)Foxp3(+) T cells and Treg function</article-title>. <source/>Gut Microbes (<year>2015</year>) <volume>6</volume>(<issue>4</issue>):<fpage>234</fpage>–<lpage>42</lpage>.<pub-id pub-id-type="doi">10.1080/19490976.2015.1056973</pub-id><pub-id pub-id-type="pmid">26230152</pub-id></mixed-citation>
</ref>
<ref id="B143">
<label>143</label>
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ochoa-Reparaz</surname><given-names>J</given-names></name><name><surname>Mielcarz</surname><given-names>DW</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Begum-Haque</surname><given-names>S</given-names></name><name><surname>Dasgupta</surname><given-names>S</given-names></name><name><surname>Kasper</surname><given-names>DL</given-names></name><etal></etal></person-group>
<article-title>A polysaccharide from the human commensal <italic>Bacteroides fragilis</italic> protects against CNS demyelinating disease</article-title>. <source/>Mucosal Immunol (<year>2010</year>) <volume>3</volume>(<issue>5</issue>):<fpage>487</fpage>–<lpage>95</lpage>.<pub-id pub-id-type="doi">10.1038/mi.2010.29</pub-id><pub-id pub-id-type="pmid">20531465</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>